WO2022027941A1 - Implant and assembly used in forming same - Google Patents

Implant and assembly used in forming same Download PDF

Info

Publication number
WO2022027941A1
WO2022027941A1 PCT/CN2021/074686 CN2021074686W WO2022027941A1 WO 2022027941 A1 WO2022027941 A1 WO 2022027941A1 CN 2021074686 W CN2021074686 W CN 2021074686W WO 2022027941 A1 WO2022027941 A1 WO 2022027941A1
Authority
WO
WIPO (PCT)
Prior art keywords
artificial
guide wire
wire
channel
implant
Prior art date
Application number
PCT/CN2021/074686
Other languages
French (fr)
Chinese (zh)
Inventor
郭扬
Original Assignee
上海端佑医疗科技有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CN202021581035.6U external-priority patent/CN212730074U/en
Priority claimed from CN202010769208.5A external-priority patent/CN114052986A/en
Application filed by 上海端佑医疗科技有限公司 filed Critical 上海端佑医疗科技有限公司
Publication of WO2022027941A1 publication Critical patent/WO2022027941A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body

Definitions

  • the present invention relates to the field of medical devices, in particular to an implant and an assembly for forming the implant.
  • the mitral valve is a complex tissue structure between the left atrium (LA) and the left ventricle (LV), consisting of the mitral valve annulus, anterior mitral valve leaflets, posterior mitral valve leaflets, mitral valve chordae tendineae and papillary muscles composition.
  • the mitral valve ensures that blood can only flow from the left atrium to the left ventricle, not the reverse.
  • a normal healthy mitral valve has multiple chordae tendineae, one end of which connects to the leaflet edge and one end to the papillary muscle located in the ventricular wall.
  • the anterior and posterior leaflets of the mitral valve When the left ventricle is in diastole, the anterior and posterior leaflets of the mitral valve are opened, the chordae tendineae are in a relaxed state, and blood flows from the left atrium to the left ventricle; when the left ventricle is in the systolic phase, the anterior and posterior leaflets of the mitral valve are in opposition under the action of blood pressure, and at the same time Due to the pulling effect of the chordae tendineae, the valve leaflets will not be turned over to the atrial side due to blood pressure. Under the combined action of the valve leaflets and the chordae tendineae, the blood flow channel between LA and LV is closed, and blood can only pass through the left ventricle.
  • the aortic valve (AV for short) flows into the aorta and sends it to various organs throughout the body.
  • AV aortic valve
  • chordae tendineae or papillary muscles have lesions, or are impacted by external forces, part of the chordae tendineae is often elongated or ruptured.
  • the left ventricle contracts, the valve leaflets are turned over to the side of the atrium due to the loss of chordae tendineae traction under the action of blood pressure. , causing the valve leaflets to fail to close tightly, resulting in blood regurgitation, that is, mitral regurgitation.
  • chordae tendineae rupture produces mild-to-moderate mitral regurgitation
  • the patient will not experience immediate clinical symptoms due to the compensatory function of the heart, but increased tension of other chordae tendineae will produce new chordae tendineae ruptures, and left atrial pressure rises High, will lead to the gradual expansion of the left atrium and mitral valve annulus, aggravate the degree of regurgitation, increase left ventricular preload, lead to left ventricular dilatation and systolic dysfunction, and then lead to left heart failure, and often lead to global heart failure, severe Endanger the patient's life and health.
  • chordae tendineae of the mitral valve Even if a few chordae tendineae are ruptured, the tension of other chordae tendineae can be increased and new chordae tendineae rupture can occur. It can be seen that the elongation or rupture of the chordae tendineae of the mitral valve has a great impact on human health and requires clinical intervention.
  • Mitral regurgitation due to lesions of the chordae tendineae or rupture of the chordae tendineae can usually be treated with drugs, surgery, or interventional procedures.
  • Drug methods such as antihypertensive, diuretic, etc.
  • cardiac surgery is still the gold standard for clinical treatment.
  • Cardiac surgery requires general anesthesia and thoracotomy, with the help of cardiopulmonary bypass to perform direct-view operation under the condition of cardiac arrest. The operation process is complicated, the risk of patient trauma and complications is high, and the hospitalization recovery time is long. It is not suitable for low cardiac function, many complications, Elderly and other high-risk surgical patients.
  • the interventional artificial chord repair device generally includes a delivery system and an implant.
  • the implant includes an artificial chord, a leaflet anchoring element and a papillary muscle anchoring element.
  • the artificial chord prosthesis enters the heart from the delivery system.
  • the leaflet anchoring elements connect the valve leaflets, and the papillary muscle anchoring elements connect the papillary muscles, thereby replacing the elongated or ruptured native chordae tendineae, eliminating or reducing mitral regurgitation.
  • the artificial chordae tendineae can be effectively treated only when they are firmly and reliably connected with the valve leaflets and papillary muscles. Because the papillary muscle belongs to the trabecular system of the ventricular muscle, the structure is relatively thick and dense, and the existing fixation methods of various interventional instruments in the ventricle (such as screw screwing, barb anchoring, etc.) can ensure firm anchoring.
  • the connection technology of artificial chordae tendineae and valve leaflets is more difficult to realize, mainly reflected in two aspects: First, the fixation reliability.
  • the material of the artificial chordae tendineae is currently polytetrafluoroethylene (PTFE) or expanded polytetrafluoroethylene (EPTFE).
  • knot; two leaflet tear.
  • PTFE polytetrafluoroethylene
  • EPTFE expanded polytetrafluoroethylene
  • the mitral valve leaflets are composed of a cavernous atrial layer and a fibrous ventricular layer, with a thickness of 1-4 mm, the strength is low, and a large local stress is generated under the pulling action of the chordae tendineae, which can easily lead to tearing of the valve leaflets, thereby causing the artificial chordae tendineae to fall off and lose the therapeutic effect.
  • the main methods of leaflet anchoring are metal anchor claw, wire knot and spacer fixing.
  • Cardiomech designed a metal anchor, which has a high surgical risk.
  • the wound caused by the anchor claw puncturing and grasping the valve leaflet is large, which is likely to cause acute perforation of the valve leaflet.
  • an object of the present invention is to provide an implant and an assembly for forming the implant to solve the problems in the prior art.
  • a first aspect of the present application provides an implant, the implant includes an artificial chordae tendineae and a papillary muscle anchoring element, the artificial chordae tendineae includes an artificial chordae tendineae body and a The anchoring valve leaflet at one end of the artificial chord body uses a self-tightening structure, and the other end of the artificial chord body is connected with the papillary muscle anchoring element.
  • the self-tightening structure for anchoring valve leaflets includes a self-tightening wire knot and a valve leaflet anchoring ring, and the valve leaflet anchoring ring is closed and locked at the self-tightening wire knot.
  • the self-tightening knot is selected from the group consisting of Bollinger knots, rope end knots, double bar knots, and flat knots.
  • the implant further includes a spacer through which the leaflet anchoring ring extends.
  • the spacer includes a first spacer and/or a second spacer, and the leaflet anchoring ring is matched with the first spacer and/or the second spacer and is locked by the self-tightening knot to form a valve Leaf anchoring structure.
  • the papillary muscle anchoring element is in a spiral shape, a barb-shaped column or a ship-anchor-like shape.
  • a second aspect of the present invention provides an assembly for forming the implant, the assembly including an artificial chord body and a papillary muscle anchoring element, the artificial chord body including a connecting segment for guiding, an artificial chord
  • the body segment and the wire segment for forming a self-tightening structure, the artificial tendon cable body is suitable for forming the artificial tendon cable in the implant, and optionally, the assembly further includes a spacer.
  • the free end of the connecting section for guiding is provided with a magnetic block, a tenon-and-mortise structure or a snap-fit structure; preferably, the connecting section for guiding can be removed by shearing.
  • the artificial tendon cable body is selected from wires.
  • a third aspect of the present invention provides an interventional artificial chord repair device, the repair device includes the component, a connecting guide wire and a delivery system, the connecting guide wire is provided in the delivery system, and the delivery system is provided with an adaptor The channel of the artificial tendon cord body in the assembly.
  • the connecting guide wire is selected from metal wires. Further, when the interventional artificial chordae tendineae repair device is implanted, the connecting guide wire and the guiding connecting segment are detachably connected.
  • the delivery system includes a first chuck and a second chuck, the first chuck is provided with a U-shaped channel, the second chuck is provided with a central channel, a first side wall channel and a second side wall channel, the One end of the first side wall channel and one end of the second side wall channel are both communicated with the central channel.
  • the other end of the first side wall channel and the other end of the second side wall channel are respectively aligned with the two openings of the U-shaped channel.
  • the interventional artificial chord repair device further comprises an auxiliary connecting guide wire and an auxiliary connecting wire
  • the auxiliary connecting guide wire is detachably connected to the connecting section for guiding
  • the auxiliary connecting wire is arranged in the U-shaped channel, and one end of the auxiliary connecting wire is detachable. It is detachably connected with the guiding connecting segment and/or the auxiliary connecting guide wire, and the other end is detachably connected with the connecting guide wire.
  • a fourth aspect of the present invention provides a method for forming the implant, the forming method comprising the steps of:
  • the artificial chordae tendineae body and the papillary muscle anchoring element are movably connected, the length of the artificial chord chordae body is adjusted, the connecting section for guiding is cut off, and the artificial chordae tendineae body and the papillary muscle anchoring element are fixedly connected to form an implant.
  • a fifth aspect of the present invention provides the use of the implant, the component or the interventional artificial chordae tendineae repair device in preparing a product for treating mitral valve regurgitation.
  • the implant, the assembly and the interventional artificial chord repair device of the present invention have the following beneficial effects:
  • Metal-free implantation can be achieved without causing metal allergy or immune response.
  • the self-tightening knot is different from the movable knot in the way of anchoring the valve leaflet. After the self-tightening knot is fixed, there will be no displacement, which reduces the friction between the knot and the valve leaflet.
  • the anchoring wound is small, and the original valve leaflet is damaged. Small, not easy to produce leaflet tear, firm fixation, good anchoring effect, and stable regurgitation treatment effect; at the same time, the self-tightening knot has less damage to the native valve leaflet than the metal anchor claw, which is conducive to the rapid endothelialization of the implant, Endothelialization is better and does not change the anatomical shape of the valve leaflets.
  • Figure 1 shows a schematic diagram of the implant of the present application.
  • Figure 2 shows a schematic diagram of four kinds of self-tightening thread knots of the present application, which are double bar knot (Figure 2a), rope end knot (Figure 2b), flat knot (Figure 2c), and Bollinger knot (Figure 2d).
  • Figure 3 is a schematic diagram showing the structure of three kinds of papillary muscle anchoring elements according to the present application, which are a spiral structure (Figure 3a), a barbed structure (Figure 3b), and a ship-anchor-like structure (Figure 3c).
  • FIG. 4 shows a schematic diagram of the interventional artificial chordae tendineae repair device of the present application.
  • FIG. 5 is a schematic diagram showing the steps of using the interventional artificial chordae tendineae repair device of the present application.
  • FIG. 6 shows another schematic diagram of the interventional artificial chord repair device of the present application.
  • FIG. 7 is a schematic diagram showing the steps of using the interventional artificial chord repair device of FIG. 6 .
  • FIG. 8 is a schematic diagram showing the steps of using the interventional artificial chordae tendineae repair device of the present application.
  • a first aspect of the present application provides an implant, the implant includes an artificial chord 1 and a papillary muscle anchoring element 2 , and the artificial chord 1 includes an artificial chord body 11 and a The self-tightening structure 12 is used for the anchoring leaflet at one end of the artificial chord body 11 , and the other end of the artificial chord body 11 is connected to the papillary muscle anchoring element 2 .
  • the self-tightening structure 12 for anchoring the leaflet includes a self-tightening wire knot 121 and a leaflet anchoring ring 122, and the leaflet anchoring ring 122 is closed and locked at the self-tightening wire knot.
  • the self-tightening wire knot 121 is a wire knot that can be locked when one end of the wire end is tightened.
  • the self-tightening thread knot 121 is selected from the group consisting of double bar knot (FIG. 2a), rope knot (FIG. 2b), flat knot (FIG. 2c), and Bollinger knot (FIG. 2d).
  • the self-tightening knot 121 is preferably a rope knot.
  • the rope knot knotting method is simple, fast and easy to implement.
  • the self-tightening knot 121 realizes that the knot can be locked when one end of the thread is tightened through different winding methods of the suture.
  • the self-tightening knot 121 and the leaflet anchoring ring 122 can be an integral structure with the artificial chord body 11, or can be three independent structures connected, or can be the artificial chord body 11 and the leaflet anchoring ring 122.
  • the self-tightening knot is a knot for locking the leaflet anchoring ring 122 with separate sutures.
  • the self-tightening wire knot 121 and the leaflet anchoring ring 122 and the artificial chord body 11 are integral structures.
  • the artificial chordae 1 is wound into a knot by itself to avoid using too many sutures in the body, and at the same time, it is easy to control, avoid the loosening of the knot, and can also improve the operation speed.
  • the implant further includes a spacer, and the leaflet anchoring ring 122 penetrates the spacer 3 .
  • the spacer 3 includes a first spacer 31 and/or a second spacer 32, the leaflet anchoring ring 122 and the first spacer 31 and/or the second spacer 32
  • the valve leaflet anchoring structure is formed by matching and locking through the self-tightening wire knot 121 .
  • the first gasket 31 is a thin sheet structure.
  • the thickness of the first gasket 31 is 0.1-2 mm, preferably 0.3-1 mm.
  • the shape of the first gasket 31 can be selected from polygonal, circular, oval, preferably quadrilateral and oval.
  • the length of the quadrilateral is 1-10 mm, preferably 2-4 mm, and the width is 1-4 mm, preferably 1-2 mm.
  • the shape of the first gasket 31 is an ellipse, the long axis of the ellipse is 1-10 mm, preferably 2-4 mm, and the short axis is 1-4 mm, preferably 1-2 mm.
  • the second gasket 32 is a thin sheet structure.
  • the thickness of the second gasket 32 is 0.1-2 mm, preferably 0.3-1 mm.
  • the shape of the second gasket 32 may be polygonal, circular or oval, preferably quadrilateral or oval.
  • the quadrilateral length is 1-10mm, preferably 2-4mm, and the width is 1-4mm, preferably 1-2mm.
  • the shape of the second gasket 32 is an ellipse, the long axis of the ellipse is 1-10 mm, preferably 2-4 mm, and the short axis is 1-4 mm, preferably 1-2 mm.
  • the materials of the first gasket 31 and the second gasket 32 can be selected from polytetrafluoroethylene (PTFE), expanded polytetrafluoroethylene (EPTFE), polyethylene terephthalate (PET), polyester, felt, Mesh wire weaving, etc.
  • the material of the first gasket 31 is preferably expanded polytetrafluoroethylene and polyethylene terephthalate.
  • first gasket 31 and the second gasket 32 may be the same or different, and the two may be used alone or in combination.
  • the first washer 31 and the second washer 32 play the roles of reducing the local traction stress of the valve leaflet, accelerating endothelialization, and increasing the anchoring stability.
  • the papillary muscle anchoring element 2 is selected from the group consisting of helix (Fig. 3a), barb (Fig. 3b), and anchor-like structure (Fig. 3c).
  • the papillary muscle anchoring element 2 can be embedded in myocardial tissue as a fixing mechanism for connecting the artificial chordae tendineae 1 with the myocardium.
  • a second aspect of the present invention provides an assembly for forming the implant, the assembly including an artificial chord body and a papillary muscle anchoring element 2, the artificial chord body including a connecting segment for guiding, an artificial tendon A cable body segment and a wire segment for forming a self-tightening structure, the artificial tendon cable body is suitable for forming the artificial tendon cable 1 in the implant.
  • the assembly further includes a gasket, and the leaflet anchoring ring 122 penetrates the gasket 3 .
  • the gasket 3 includes a first gasket 31 and a second gasket 32, and the leaflet anchoring ring 122 is matched with the first gasket 31 and the second gasket 32 and passed through the The self-tightening knot 121 is locked to form a leaflet anchoring structure.
  • the artificial tendon cable body is selected from wires. Specifically, the wire meets the requirements of the YY 0167-2020 standard.
  • the diameter specifications of the wire can be selected from 5-0, 4-0, 3-0, 2-0/T, and 2-0.
  • the diameter of the wire is preferably 3-0, 2-0.
  • Clinical data show that 3-0 and 2-0 diameter wires are closer to the needs of the chordae tendineae.
  • the structure of the wire can be single or multiple braided.
  • the structure of the wire is preferably a single strand. Single strands are more stable in structure, and multiple strands run the risk of snagging, twisting or twisting.
  • the material of the wire can be selected from polytetrafluoroethylene (PTFE), expanded polytetrafluoroethylene (EPTFE), polyethylene terephthalate (PET), ultra-high molecular weight polyethylene (UHMWPE), mulberry silk, Nylon, cotton, etc.
  • the material of the wire rod is preferably polytetrafluoroethylene (PTFE) or expanded polytetrafluoroethylene (EPTFE).
  • PTFE polytetrafluoroethylene
  • EPTFE expanded polytetrafluoroethylene
  • EPTFE expanded polytetrafluoroethylene
  • the guiding connecting segment is used to assist in guiding the movement of the artificial chord body segment and the line segment for forming the self-tightening structure during transportation.
  • the connecting section for guiding can realize development under DSA, and you can choose to add developer to the connecting section for guiding, or wrap the developing wire, or the detachable connecting piece is made of developable materials, such as gold, platinum, PtW alloy, Tantalum or PtIr alloy, etc.
  • developable materials such as gold, platinum, PtW alloy, Tantalum or PtIr alloy, etc.
  • the line segment for forming the self-tightening structure corresponds to the line segment for forming the self-tightening structure 12 for anchoring the leaflet in the implant, while the main segment of the artificial chordae tendineae Then it corresponds to the line segment in the implant as the body of the artificial chordae tendineae.
  • the guiding connecting section, the artificial tendon body section and the self-tightening structure forming line can be different sections of one wire, three wires, or two wires.
  • the guiding connecting section and the artificial tendon are
  • the body segment is a wire
  • the wire segment for forming the self-tightening structure is another wire.
  • other combinations are possible as long as the implant can be formed.
  • the papillary muscle anchoring element 2 is selected from the group consisting of helix (Fig. 3a), barb (Fig. 3b), and anchor-like structure (Fig. 3c).
  • the papillary muscle anchoring element 2 can be embedded in myocardial tissue as a fixing mechanism for connecting the artificial chordae tendineae 1 with the myocardium.
  • a third aspect of the present invention provides an interventional artificial chord repair device, the repair device includes an implant, a connecting guide wire 41 and a delivery system 5 , and the connecting guide wire 41 is provided in the delivery system 5 .
  • the delivery system 5 is provided with a channel adapted to the artificial tendon cord body in the assembly.
  • the connecting guide wire 41 is selected from metal wires. Preferably, it is selected from metal wires that are elastic and have good supporting properties.
  • the diameter of the connecting guide wire 41 is 0.2-1.5 mm, preferably 0.5-1.0 mm.
  • the structure of the connecting guide wire 41 can be a single strand, a mandrel plus inner and outer springs, etc., preferably a single strand.
  • the material of the metal wire can be selected from nickel-titanium alloy, stainless steel, titanium alloy, preferably nickel-titanium alloy.
  • the head end of the connecting guide wire 41 is in the shape of a sharp needle.
  • the connecting guide wire 41 is detachably connected to the free end of the connecting segment for guiding.
  • the detachable connection method may be a snap, magnetic attraction, tenon and tenon, coupling, etc., which is not limited in the present invention.
  • the delivery system 5 includes a first chuck 51 and a second chuck 52 , the first chuck 51 is provided with a U-shaped channel 511 , and the second chuck 52 is provided with a central channel 521 , the first side wall channel 522 and the second side wall channel 523, one end of the first side wall channel 522 and one end of the second side wall channel 523 are communicated with the central channel 521.
  • the first side wall channel 522 is another One end and the other end of the second sidewall channel 523 are aligned with the two openings of the U-shaped channel 511 respectively.
  • the first chuck 51 and the second chuck 52 are respectively set at the same position on both sides of the leaflet 6 , that is, the first chuck 51 and the second chuck 52 can be aligned with the leaflet 6 apart.
  • first chuck 51 and the second chuck 52 can move relative to each other, and when they are close to each other, they clamp the valve leaflet.
  • the connecting guide The wire 41 can enter the U-shaped channel 511 after passing through the second gasket 32 , the valve leaflet 6 , and the first gasket 31 .
  • the first gasket 31 is pre-placed between the U-shaped channel 511 and the valve leaflet in the first collet 51
  • the second gasket 32 is pre-placed in the center of the second collet 52 .
  • the connecting guide wire 41 is pre-placed in the central channel 521; the preset connecting guide wire 41 is obliquely inserted into the first side wall channel 522; the self-tightening wire knot 121 is wound on the connecting guide wire 41, and the connecting segment is placed in the second side wall channel 523.
  • the interventional artificial chordae repair device is used to form the implant.
  • the method for forming the implant includes the following steps:
  • a part of the artificial tendon cable body is wound around the connecting guide wire 41; when the first collet 51 and the second collet 52 are clamped, the opening of the first side wall channel 522 and the second side wall channel 523 After the openings of the valve are aligned with the two openings of the U-shaped channel 511, the connecting guide wire 41 is pushed in the direction of the arrow shown in the figure to penetrate the second gasket 32, the valve leaflet 6, the first gasket 31 in turn, and enter the U-shaped channel 511;
  • the connecting guide wire 41 is withdrawn in the direction of the arrow shown in the figure, and the connecting guide wire 41 will drive the connecting section for guiding, the main body section of the artificial chordae tendineae, and the line section for forming the self-tightening structure to pass through the second gasket 32, After the valve leaflet 6 and the first gasket 31, the self-tightening structure forming line segment is closed at the self-tightening wire knot to form the valve leaflet anchoring ring 122;
  • the interventional artificial chord repair device further includes an auxiliary connecting guide wire 42 and an auxiliary connecting wire 43 , and the auxiliary connecting guide wire 42 is detachably connected to the connecting segment for guiding.
  • the auxiliary connecting wire 43 is arranged in the U-shaped channel 511 , one end is detachably connected to the guiding connecting section and/or the auxiliary connecting wire 42 , and the other end is detachably connected to the connecting wire 41 .
  • the setting of the auxiliary connecting guide wire 42 and the auxiliary connecting wire 43 can complete the implantation more quickly.
  • the detachable connection is selected from snap, magnetic attraction, tenon and tenon, coupling and the like.
  • the function of the auxiliary connection guide wire 42 is to guide the wire segment for forming the self-tightening structure and the main body segment of the artificial chordae tendineae into the U-shaped channel 511 through the guiding connection segment connected at one end.
  • the auxiliary connecting wire 43 includes a first connecting end 431 and a second connecting end 432 .
  • the first connecting end 431 is connected to the connecting guide wire 41
  • the second connecting end 432 is connected to the auxiliary connecting guide wire 42 . connected at one end.
  • the connection between the first connection end 431 and the connection guide wire 41 and the connection between the second connection end 432 and the auxiliary connection guide wire 42 are all detachable connections.
  • the function of the auxiliary connecting wire 43 is to help the connecting guide wire 41 to realize the connection with the connecting segment for guiding.
  • the auxiliary connecting wire 43 is detachably connected with the guiding connecting section.
  • the detachable connection is selected from snap, magnetic attraction, tenon and tenon, coupling and the like.
  • the auxiliary connecting wire 43 can realize development under DSA, and a developer can be added to the auxiliary connecting wire 43, or a metal wire can be wound, or the connection structure at both ends of the auxiliary connecting wire 43 can be made of metal material.
  • the connecting guide wire 41 and the auxiliary connecting guide wire 42 are preset in the central channel 521 ; the auxiliary connecting wire 43 is preset in the U-shaped channel 511 .
  • the method for forming the implant includes the following steps:
  • part of the artificial tendon cable body is wound around the connecting guide wire 41; when the first chuck 51 and the second chuck 52 are clamped, the opening of the first side wall channel 522, the second side wall After the openings of the channel 523 are respectively aligned with the two openings of the U-shaped channel 511, push the connecting guide wire 41 into the U-shaped channel 511 in the direction of the arrow shown in the figure and then connect with the second connection end 432; at the same time, push the auxiliary wire 41 in the direction of the arrow in the figure.
  • the connecting guide wire 42 enters the U-shaped channel 511 and is connected to the first connecting end 431 .
  • the guiding connecting section is carried by the auxiliary connecting guide wire 42 and enters the U-shaped channel 511 to connect with the first connecting end 431 .
  • the connecting guide wire 41 and the auxiliary connecting guide wire 42 both penetrate the second gasket 32 , the valve leaflet 6 , and the first gasket 31 in sequence and then enter the U-shaped channel 511 .
  • the auxiliary connection guide wire 42 is withdrawn in the direction of the arrow shown in the figure. After the auxiliary connection guide wire 42 is withdrawn, it is no longer used. At the same time, the connection guide wire 41 is withdrawn, and the connection guide wire 41 drives the auxiliary connection wire 43 to move.
  • the auxiliary connecting wire 43 drives the guiding connecting section, the artificial chordae body section, and the self-tightening structure forming section to move, and the self-tightening structure forming section closes the loop at the self-tightening knot to form the leaflet anchoring ring 122 .
  • the auxiliary connecting wire 43 drives the connecting segment for guiding, the body segment of the artificial chordae tendineae, and the segment for forming the self-tightening structure to move through the first gasket 31 , the valve leaflet 6 , and the second gasket 32 in sequence.
  • a fourth aspect of the present application provides the use of the implant, the assembly or the interventional artificial chordae tendineae repair device in the manufacture of a product for treating mitral valve regurgitation.
  • the steps of using the interventional artificial chordae tendineae repair device are as follows: the delivery system 5 enters the atrium from the atrial septum through the universal sheath ( FIG. 8 a ); Complete valve leaflet clamping with assistance (Figure 8b); release gasket 3 and valve leaflet with self-tightening structure 12, pull back delivery system 5, and withdraw artificial chordae tendineae 1 ( Figure 8c); use delivery system 5 to anchor papillary muscle Element 2 is anchored in the myocardium of the left ventricle (Fig. 8d); the delivery system 5 is withdrawn.
  • the papillary muscle anchoring element 2 is connected to one end of the connecting segment for guidance, and the length of the artificial chordae tendineae is adjusted by ultrasound imaging to ensure no reflux (Fig. 8e). After adjusting the length, cut off the connecting segment for guiding, and the final state of the implant in the heart is shown in Fig. 8f.
  • the use of the implant or the interventional artificial chordae tendineae repair device can complete the fixation of the artificial chordae tendineae and valve leaflets through an interventional manner, without the need for thoracotomy, with less surgical trauma and quicker recovery of the patient. And the fixation is firm, the valve leaflet is not easily torn, and at the same time, it is conducive to the rapid endothelialization of the implant and the healing of the wound surface.
  • the present invention effectively overcomes various shortcomings in the prior art and has high industrial utilization value.

Abstract

An implant and an assembly used in forming same. The implant comprises an artificial chordae tendineae (1) and a papillary muscle anchor element (2). The artificial chordae tendineae (1) comprises an artificial chordae tendineae body (11) and a self-tightening structure (12) formed on one end of the artificial chordae tendineae body (11) and used for anchoring a leaflet. The other end of the artificial chordae tendineae body (11) connects to the papillary muscle anchor element (2). The implant optimizes a leaflet securing means of the artificial chordae tendineae prosthesis, completing the securing of the artificial chordae tendineae to the leaflet by means of interventional surgery, and opening the chest is unnecessary, surgery trauma is low, and patient recovery is rapid; a self-tightening thread knot will not be displaced, decreasing friction between the thread knot and the leaflet, the wound surface of the anchor is small, there is little damage to the native leaflet, the anchoring effect is good, and the reflux treatment effect is stable; additionally, rapid endothelialization of the implant is facilitated, endothelialization results are better, and the anatomical form of the leaflet will not be changed.

Description

一种植入物及用于形成植入物的组件An implant and components for forming the implant 技术领域technical field
本发明涉及医疗器械领域,特别是涉及一种植入物及用于形成植入物的组件。The present invention relates to the field of medical devices, in particular to an implant and an assembly for forming the implant.
背景技术Background technique
二尖瓣为左心房(简称LA)和左心室(简称LV)之间的复杂组织结构,由二尖瓣环、二尖瓣前叶、二尖瓣后叶及二尖瓣腱索及乳头肌组成。二尖瓣,可以保证血液仅能从左心房流向左心室,不能反向流动。正常健康的二尖瓣具有多根腱索,腱索一端连接瓣叶边缘,一端与位于心室壁的乳头肌连接。当左心室处于舒张期时,二尖瓣前后叶打开,腱索呈松弛状态,血液从左心房流向左心室;左心室处于收缩期时,二尖瓣前后叶在血液压力作用下对合,同时由于腱索的牵拉作用,瓣叶不会由于血液压力翻转到心房侧,在瓣叶及腱索的共同作用下,LA与LV之间的血流通道被关闭,血液只能从左心室经过主动脉瓣(简称AV)流向主动脉并送往全身各器官。当腱索或乳头肌出现病变,或受到外力冲击时,往往导致部分腱索伸长或断裂,当左心室收缩时,瓣叶由于失去腱索牵拉,在血液压力作用下翻转至心房一侧,导致瓣叶无法紧密对合,进而产生血液返流,即二尖瓣反流。当发生急性重度二尖瓣反流时(如撞击等外力导致的腱索断裂),血液动力学发生急剧改变,大量动脉血液反流至左心房,导致肺部淤血,毛细血管压力急剧上升,发生急性肺水肿,出现呼吸困难、咳血等严重临床症状,病人如不立即进行临床干预,会导致死亡。如果仅个别腱索断裂产生轻中度二尖瓣反流,由于心脏的代偿功能,病人不会立即出现临床症状,但其它腱索张力增高会产生新的腱索断裂,且左心房压力升高,会导致左心房及二尖瓣瓣环逐步扩大,加剧反流程度,增加左室内前负荷,导致左室扩张和收缩机能障碍,进而发生左心衰,并往往会导致全心衰,严重危及病人生命健康。腱索出现病变或者腱索断裂后均不能自行修复,即使少数腱索断裂,也可使其它腱索张力增高而发生新的腱索断裂。由此可见,二尖瓣腱索伸长或断裂对人体健康影响极大,需要临床干预治疗。The mitral valve is a complex tissue structure between the left atrium (LA) and the left ventricle (LV), consisting of the mitral valve annulus, anterior mitral valve leaflets, posterior mitral valve leaflets, mitral valve chordae tendineae and papillary muscles composition. The mitral valve ensures that blood can only flow from the left atrium to the left ventricle, not the reverse. A normal healthy mitral valve has multiple chordae tendineae, one end of which connects to the leaflet edge and one end to the papillary muscle located in the ventricular wall. When the left ventricle is in diastole, the anterior and posterior leaflets of the mitral valve are opened, the chordae tendineae are in a relaxed state, and blood flows from the left atrium to the left ventricle; when the left ventricle is in the systolic phase, the anterior and posterior leaflets of the mitral valve are in opposition under the action of blood pressure, and at the same time Due to the pulling effect of the chordae tendineae, the valve leaflets will not be turned over to the atrial side due to blood pressure. Under the combined action of the valve leaflets and the chordae tendineae, the blood flow channel between LA and LV is closed, and blood can only pass through the left ventricle. The aortic valve (AV for short) flows into the aorta and sends it to various organs throughout the body. When the chordae tendineae or papillary muscles have lesions, or are impacted by external forces, part of the chordae tendineae is often elongated or ruptured. When the left ventricle contracts, the valve leaflets are turned over to the side of the atrium due to the loss of chordae tendineae traction under the action of blood pressure. , causing the valve leaflets to fail to close tightly, resulting in blood regurgitation, that is, mitral regurgitation. When acute severe mitral regurgitation occurs (such as rupture of the chordae tendineae caused by external forces such as impact), the hemodynamics changes sharply, and a large amount of arterial blood refluxes into the left atrium, resulting in pulmonary congestion and a sharp increase in capillary pressure. Acute pulmonary edema, with severe clinical symptoms such as dyspnea and hemoptysis, will lead to death if the patient does not receive immediate clinical intervention. If only individual chordae tendineae rupture produces mild-to-moderate mitral regurgitation, the patient will not experience immediate clinical symptoms due to the compensatory function of the heart, but increased tension of other chordae tendineae will produce new chordae tendineae ruptures, and left atrial pressure rises High, will lead to the gradual expansion of the left atrium and mitral valve annulus, aggravate the degree of regurgitation, increase left ventricular preload, lead to left ventricular dilatation and systolic dysfunction, and then lead to left heart failure, and often lead to global heart failure, severe Endanger the patient's life and health. Even if a few chordae tendineae are ruptured, the tension of other chordae tendineae can be increased and new chordae tendineae rupture can occur. It can be seen that the elongation or rupture of the chordae tendineae of the mitral valve has a great impact on human health and requires clinical intervention.
由于腱索出现病变或者腱索断裂产生的二尖瓣反流通常可以采取药物、外科手术或介入手术方式进行治疗。药物方式(如降压、利尿等)为对症治疗,仅能减轻临床症状,不能从根本解决问题。对于中重度二尖瓣反流,心脏外科手术目前仍是临床治疗的金标准。心脏外科手术需要全麻开胸,借助体外循环在心脏停跳情况下进行直视操作,手术过程复杂、病人创伤及并发症风险高、住院恢复时间长,不适于心功能低下、合并症多、高龄等外科手术高危患者。Mitral regurgitation due to lesions of the chordae tendineae or rupture of the chordae tendineae can usually be treated with drugs, surgery, or interventional procedures. Drug methods (such as antihypertensive, diuretic, etc.) are symptomatic treatment, which can only alleviate clinical symptoms, but cannot fundamentally solve the problem. For moderate to severe mitral regurgitation, cardiac surgery is still the gold standard for clinical treatment. Cardiac surgery requires general anesthesia and thoracotomy, with the help of cardiopulmonary bypass to perform direct-view operation under the condition of cardiac arrest. The operation process is complicated, the risk of patient trauma and complications is high, and the hospitalization recovery time is long. It is not suitable for low cardiac function, many complications, Elderly and other high-risk surgical patients.
介入手术通过穿刺,在现代影像设备如三维超声、造影的导航下,经外周血管将器械送入心脏,在心脏不停跳的情况下完成手术,极大地降低了创伤程度和并发症风险,是外科高危患者唯一的治疗方式。介入人工腱索修复装置一般包括输送系统和植入物两部分组成,所述植入物包括人工腱索、瓣叶锚固元件和乳头肌锚固元件,人工腱索假体由输送系统进入心脏,瓣叶锚固元件连接瓣叶,乳头肌锚固元件连接乳头肌,从而替代伸长或断裂的原生腱索,消除或减轻二尖瓣反流。人工腱索只有牢固可靠地与瓣叶及乳头肌进行连接才能有效实现治疗。由于乳头肌属于心室肌小梁系统,结构相对粗大致密,现有各种介入器械心室内的固定方式(如螺旋旋入,倒刺锚固等)均可以保证牢固锚定。人工腱索与瓣叶的连接技术实现的难度更大,主要体现在两方面:一、固定牢靠度。为避免人工腱索假体在心脏内产生血栓,目前人工腱索的材质为聚四氟乙烯(PTFE)或膨体聚四氟乙烯(EPTFE),这两种材料润滑性极好,不易牢固打结;二、瓣叶撕裂。心室收缩期瓣叶上翻,牵拉腱索,有文献表明,期间腱索受力最大可达1.7N,二尖瓣瓣叶为海绵状心房层与纤维状心室层组成,厚度为1-4毫米,强度较低,在腱索牵拉作用下产生较大的局部应力,易导致瓣叶撕裂,进而使人工腱索脱落,失去治疗效果。已知现有技术中,瓣叶锚固的主要方式为金属锚爪、线结及垫片固定方式。如Cardiomech公司设计一款金属锚爪,此类锚固方式手术风险较高,一方面锚爪穿刺和抓握瓣叶造成的创面大,容易造成瓣叶急性穿孔,另一方面金属件植入后可能造成金属过敏或免疫反应。还可能产生其他问题,如对瓣叶产生额外负重改变瓣叶表面形态,影响血流动力学等,同时金属锚爪不利于组织生长,不能在短时间内形成内皮化。Interventional surgery is performed through puncture. Under the navigation of modern imaging equipment such as three-dimensional ultrasound and angiography, the device is sent into the heart through peripheral blood vessels, and the operation is completed without the heart beating, which greatly reduces the degree of trauma and the risk of complications. The only treatment option for high-risk surgical patients. The interventional artificial chord repair device generally includes a delivery system and an implant. The implant includes an artificial chord, a leaflet anchoring element and a papillary muscle anchoring element. The artificial chord prosthesis enters the heart from the delivery system. The leaflet anchoring elements connect the valve leaflets, and the papillary muscle anchoring elements connect the papillary muscles, thereby replacing the elongated or ruptured native chordae tendineae, eliminating or reducing mitral regurgitation. The artificial chordae tendineae can be effectively treated only when they are firmly and reliably connected with the valve leaflets and papillary muscles. Because the papillary muscle belongs to the trabecular system of the ventricular muscle, the structure is relatively thick and dense, and the existing fixation methods of various interventional instruments in the ventricle (such as screw screwing, barb anchoring, etc.) can ensure firm anchoring. The connection technology of artificial chordae tendineae and valve leaflets is more difficult to realize, mainly reflected in two aspects: First, the fixation reliability. In order to prevent the artificial chordae tendinea prosthesis from causing thrombosis in the heart, the material of the artificial chordae tendineae is currently polytetrafluoroethylene (PTFE) or expanded polytetrafluoroethylene (EPTFE). knot; two, leaflet tear. During ventricular systole, the valve leaflets are turned up and the chordae tendineae are stretched. Some literatures show that the maximum force on the chordae tendineae during ventricular systole can reach 1.7N. The mitral valve leaflets are composed of a cavernous atrial layer and a fibrous ventricular layer, with a thickness of 1-4 mm, the strength is low, and a large local stress is generated under the pulling action of the chordae tendineae, which can easily lead to tearing of the valve leaflets, thereby causing the artificial chordae tendineae to fall off and lose the therapeutic effect. It is known in the prior art that the main methods of leaflet anchoring are metal anchor claw, wire knot and spacer fixing. For example, Cardiomech designed a metal anchor, which has a high surgical risk. On the one hand, the wound caused by the anchor claw puncturing and grasping the valve leaflet is large, which is likely to cause acute perforation of the valve leaflet. Causes metal allergy or immune response. Other problems may also arise, such as extra load on the valve leaflets, changing the surface morphology of the valve leaflets, affecting hemodynamics, etc. At the same time, the metal anchors are not conducive to tissue growth and cannot form endothelialization in a short time.
发明内容SUMMARY OF THE INVENTION
鉴于以上所述现有技术的缺点,本发明的目的在于提供一种植入物及用于形成植入物的组件,用于解决现有技术中的问题。In view of the above-mentioned shortcomings of the prior art, an object of the present invention is to provide an implant and an assembly for forming the implant to solve the problems in the prior art.
为实现上述目的及其他相关目的,本申请第一方面提供一种植入物,所述植入物包括人工腱索和乳头肌锚固元件,所述人工腱索包括人工腱索本体及形成于所述人工腱索本体一端的锚固瓣叶用自紧结构,所述人工腱索本体的另一端与乳头肌锚固元件连接。In order to achieve the above object and other related objects, a first aspect of the present application provides an implant, the implant includes an artificial chordae tendineae and a papillary muscle anchoring element, the artificial chordae tendineae includes an artificial chordae tendineae body and a The anchoring valve leaflet at one end of the artificial chord body uses a self-tightening structure, and the other end of the artificial chord body is connected with the papillary muscle anchoring element.
所述锚固瓣叶用自紧结构包括自紧线结及瓣叶锚固环,所述瓣叶锚固环在所述自紧线结处闭环并锁紧。The self-tightening structure for anchoring valve leaflets includes a self-tightening wire knot and a valve leaflet anchoring ring, and the valve leaflet anchoring ring is closed and locked at the self-tightening wire knot.
所述自紧线结选自布林结、绳头结、双套结、平结。The self-tightening knot is selected from the group consisting of Bollinger knots, rope end knots, double bar knots, and flat knots.
优选地,所述植入物还包括垫片,所述瓣叶锚固环贯穿所述垫片。所述垫片包括第一垫片和/或第二垫片,所述瓣叶锚固环与所述第一垫片和/或第二垫片相配合并经所述自紧线结锁 紧形成瓣叶锚固结构。Preferably, the implant further includes a spacer through which the leaflet anchoring ring extends. The spacer includes a first spacer and/or a second spacer, and the leaflet anchoring ring is matched with the first spacer and/or the second spacer and is locked by the self-tightening knot to form a valve Leaf anchoring structure.
所述乳头肌锚固元件呈螺旋状、设有倒刺的柱状或类船锚状。The papillary muscle anchoring element is in a spiral shape, a barb-shaped column or a ship-anchor-like shape.
本发明第二方面提供一种用于形成所述植入物的组件,所述组件包括人工腱索线体和乳头肌锚固元件,所述人工腱索线体包括引导用连接段、人工腱索本体段及自紧结构形成用线段,所述人工腱索线体适于形成所述植入物中的人工腱索,可选的,所述组件还包括垫片。A second aspect of the present invention provides an assembly for forming the implant, the assembly including an artificial chord body and a papillary muscle anchoring element, the artificial chord body including a connecting segment for guiding, an artificial chord The body segment and the wire segment for forming a self-tightening structure, the artificial tendon cable body is suitable for forming the artificial tendon cable in the implant, and optionally, the assembly further includes a spacer.
所述引导用连接段的自由端设有磁块、榫卯结构或卡扣结构;优选的,所述引导用连接段可被剪切去除。The free end of the connecting section for guiding is provided with a magnetic block, a tenon-and-mortise structure or a snap-fit structure; preferably, the connecting section for guiding can be removed by shearing.
所述人工腱索线体选自线材。The artificial tendon cable body is selected from wires.
本发明第三方面提供一种介入人工腱索修复装置,所述修复装置包括所述组件、连接导丝和输送系统,所述连接导丝设于输送系统内,所述输送系统设有适配所述组件中人工腱索线体的通道。A third aspect of the present invention provides an interventional artificial chord repair device, the repair device includes the component, a connecting guide wire and a delivery system, the connecting guide wire is provided in the delivery system, and the delivery system is provided with an adaptor The channel of the artificial tendon cord body in the assembly.
优选地,所述连接导丝选自金属丝。进一步的,在介入人工腱索修复装置植入时,连接导丝与引导用连接段可拆卸连接。Preferably, the connecting guide wire is selected from metal wires. Further, when the interventional artificial chordae tendineae repair device is implanted, the connecting guide wire and the guiding connecting segment are detachably connected.
优选地,输送系统包括第一夹头和第二夹头,第一夹头内设有U型通道,第二夹头设有中心通道、第一侧壁通道与第二侧壁通道,所述第一侧壁通道一端、第二侧壁通道一端均与中心通道连通,在使用状态下,第一侧壁通道另一端、第二侧壁通道另一端分别与U型通道的两个开口对齐。Preferably, the delivery system includes a first chuck and a second chuck, the first chuck is provided with a U-shaped channel, the second chuck is provided with a central channel, a first side wall channel and a second side wall channel, the One end of the first side wall channel and one end of the second side wall channel are both communicated with the central channel. In the use state, the other end of the first side wall channel and the other end of the second side wall channel are respectively aligned with the two openings of the U-shaped channel.
优选地,所述介入人工腱索修复装置还包括辅助连接导丝和辅助连接线,所述辅助连接导丝与引导用连接段可拆卸连接,所述辅助连接线设于U型通道内,一端与引导用连接段和/或辅助连接导丝可拆卸连接,另一端与连接导丝可拆卸连接。Preferably, the interventional artificial chord repair device further comprises an auxiliary connecting guide wire and an auxiliary connecting wire, the auxiliary connecting guide wire is detachably connected to the connecting section for guiding, and the auxiliary connecting wire is arranged in the U-shaped channel, and one end of the auxiliary connecting wire is detachable. It is detachably connected with the guiding connecting segment and/or the auxiliary connecting guide wire, and the other end is detachably connected with the connecting guide wire.
本发明第四方面提供所述植入物的形成方法,所述形成方法包括以下步骤:A fourth aspect of the present invention provides a method for forming the implant, the forming method comprising the steps of:
1)将人工腱索线体的部分线段缠绕连接导丝;1) Winding part of the artificial tendon cable body to connect the guide wire;
2)将输送系统的第一夹头和第二夹头夹紧,以使设于第二夹头上的第一侧壁通道的开口、第二侧壁通道的开口分别与设于第一夹头上的U型通道的两个开口对齐;2) Clamp the first chuck and the second chuck of the conveying system, so that the opening of the first side wall channel and the opening of the second side wall channel provided on the second chuck are The two openings of the U-shaped channel on the head are aligned;
3)选自以下任一步或两步:3) Choose one or two steps from the following:
i.沿第一侧壁通道推动连接导丝,使连接导丝进入U型通道,与人工腱索线体上的引导用连接段连接;i. Push the connecting guide wire along the first side wall channel, so that the connecting guide wire enters the U-shaped channel and is connected with the guiding connecting segment on the artificial tendon cable body;
ii.沿第二侧壁通道推动辅助连接导丝以使人工腱索线体上的引导用连接段与设于U型通道内的辅助连接线相连接,沿第一侧壁通道推动连接导丝,使连接导丝进入U型通道,与辅助连接线相连接,撤出辅助连接导丝;ii. Push the auxiliary connection guide wire along the second side wall passage to connect the guide on the artificial tendon cable body with the auxiliary connection wire arranged in the U-shaped passage, and push the connection guide wire along the first side wall passage , make the connecting guide wire enter the U-shaped channel, connect with the auxiliary connecting wire, and withdraw the auxiliary connecting guide wire;
4)回撤连接导丝以使人工腱索线体形成自紧线结及瓣叶锚固环;4) withdraw the connecting guide wire to make the artificial tendon cord body form a self-tightening knot and a leaflet anchoring ring;
5)继续回撤连接导丝,使引导用连接段、人工腱索本体段穿过自紧线结;5) Continue to withdraw the connecting guide wire, so that the connecting section for guiding and the body section of the artificial chordae tendinea pass through the self-tightening knot;
6)收紧自紧线结;6) Tighten the self-tightening knot;
7)使人工腱索线体与乳头肌锚固元件活动连接,调整人工腱索本体的长度,剪除引导用连接段,将人工腱索本体与乳头肌锚固元件固定连接,即形成植入物。7) The artificial chordae tendineae body and the papillary muscle anchoring element are movably connected, the length of the artificial chord chordae body is adjusted, the connecting section for guiding is cut off, and the artificial chordae tendineae body and the papillary muscle anchoring element are fixedly connected to form an implant.
本发明第五方面提供所述的植入物、所述组件或所述介入人工腱索修复装置在制备治疗二尖瓣反流产品中的用途。A fifth aspect of the present invention provides the use of the implant, the component or the interventional artificial chordae tendineae repair device in preparing a product for treating mitral valve regurgitation.
如上所述,本发明的植入物、所述组件以及介入人工腱索修复装置,具有以下有益效果:As described above, the implant, the assembly and the interventional artificial chord repair device of the present invention have the following beneficial effects:
1)优化了人工腱索假体的瓣叶固定方式,该方式替代外科开胸手术,通过介入方式完成人工腱索与瓣叶的固定,降低手术对机体的创伤。1) The leaflet fixation method of the artificial chordae tendineae prosthesis is optimized. This method replaces surgical thoracotomy, and the fixation of the artificial chordae tendineae and the valve leaflets is completed through interventional methods, reducing the trauma to the body.
2)可以实现无金属植入,不会造成金属过敏或免疫反应。2) Metal-free implantation can be achieved without causing metal allergy or immune response.
3)自紧线结作为锚固瓣叶的方式不同于活动结,自紧线结固定后不会发生移位,减少了线结与瓣叶之间的摩擦,锚固创面小,对原生瓣叶损伤小,不易产生瓣叶撕裂,固定牢靠、锚固效果好,返流治疗效果稳定;同时自紧线结相对于金属锚爪对原生瓣叶的损伤小,有利于植入物的快速内皮化、内皮化效果更好,不会改变瓣叶的解剖学形态。3) The self-tightening knot is different from the movable knot in the way of anchoring the valve leaflet. After the self-tightening knot is fixed, there will be no displacement, which reduces the friction between the knot and the valve leaflet. The anchoring wound is small, and the original valve leaflet is damaged. Small, not easy to produce leaflet tear, firm fixation, good anchoring effect, and stable regurgitation treatment effect; at the same time, the self-tightening knot has less damage to the native valve leaflet than the metal anchor claw, which is conducive to the rapid endothelialization of the implant, Endothelialization is better and does not change the anatomical shape of the valve leaflets.
附图说明Description of drawings
图1显示为本申请的植入物示意图。Figure 1 shows a schematic diagram of the implant of the present application.
图2显示为本申请的四种自紧线结示意图,依次为双套结(图2a)、绳头结(图2b)、平结(图2c)、布林结(图2d)。Figure 2 shows a schematic diagram of four kinds of self-tightening thread knots of the present application, which are double bar knot (Figure 2a), rope end knot (Figure 2b), flat knot (Figure 2c), and Bollinger knot (Figure 2d).
图3显示为本申请的三种乳头肌锚固元件结构示意图,依次为螺旋结构(图3a)、倒刺结构(图3b)、类船锚结构(图3c)。Figure 3 is a schematic diagram showing the structure of three kinds of papillary muscle anchoring elements according to the present application, which are a spiral structure (Figure 3a), a barbed structure (Figure 3b), and a ship-anchor-like structure (Figure 3c).
图4显示为本申请的介入人工腱索修复装置示意图。FIG. 4 shows a schematic diagram of the interventional artificial chordae tendineae repair device of the present application.
图5显示为本申请的介入人工腱索修复装置的使用步骤示意图。FIG. 5 is a schematic diagram showing the steps of using the interventional artificial chordae tendineae repair device of the present application.
图6显示为本申请的介入人工腱索修复装置另一示意图。FIG. 6 shows another schematic diagram of the interventional artificial chord repair device of the present application.
图7显示为图6的介入人工腱索修复装置的使用步骤示意图。FIG. 7 is a schematic diagram showing the steps of using the interventional artificial chord repair device of FIG. 6 .
图8显示为本申请的介入人工腱索修复装置使用时的步骤示意图。FIG. 8 is a schematic diagram showing the steps of using the interventional artificial chordae tendineae repair device of the present application.
元件标号说明Component label description
1         人工腱索1 Artificial tendine cord
11                     人工腱索本体11 Artificial tendon body
12                     瓣叶用自紧结构12 Self-tightening structure for leaflets
121                    自紧线结121 Self-tightening knot
122                    瓣叶锚固环122 Leaflet anchoring ring
2                      乳头肌锚固元件2 Papillary Muscle Anchoring Element
3                      垫片3 Spacers
31                     第一垫片31 The first gasket
32                     第二垫片32 Second gasket
41                     连接导丝41 Connect the guide wire
42                     辅助连接导丝42 Auxiliary connection guide wire
43                     辅助连接线43 Auxiliary cable
431                    第一连接端431 The first connection terminal
432                    第二连接端432 Second connection terminal
5                      输送系统5 Conveyor system
51                     第一夹头51 The first chuck
511                    U型通道511 U-shaped channel
52                     第二夹头52 Second chuck
521                    中心通道521 Center aisle
522                    第一侧壁通道522 First side wall channel
523                    第二侧壁通道523 Second sidewall channel
6                      瓣叶6 leaflets
具体实施方式detailed description
以下由特定的具体实施例说明本发明的实施方式,熟悉此技术的人士可由本说明书所揭露的内容轻易地了解本发明的其他优点及功效。The embodiments of the present invention are described below by specific embodiments, and those skilled in the art can easily understand other advantages and effects of the present invention from the contents disclosed in this specification.
请参阅图1至图8。须知,本说明书所附图式所绘示的结构、比例、大小等,均仅用以配合说明书所揭示的内容,以供熟悉此技术的人士了解与阅读,并非用以限定本发明可实施的限定条件,故不具技术上的实质意义,任何结构的修饰、比例关系的改变或大小的调整,在不影响本发明所能产生的功效及所能达成的目的下,均应仍落在本发明所揭示的技术内容能涵盖的范围内。同时,本说明书中所引用的如“上”、“下”、“左”、“右”、“中间” 及“一”等的用语,亦仅为便于叙述的明了,而非用以限定本发明可实施的范围,其相对关系的改变或调整,在无实质变更技术内容下,当亦视为本发明可实施的范畴。See Figures 1 through 8. It should be noted that the structures, proportions, sizes, etc. shown in the drawings in this specification are only used to cooperate with the contents disclosed in the specification, so as to be understood and read by those who are familiar with the technology, and are not used to limit the implementation of the present invention. Restricted conditions, it does not have technical substantive significance, any structural modification, proportional relationship change or size adjustment, without affecting the effect that the present invention can produce and the purpose that can be achieved, should still fall within the present invention. The disclosed technical content can cover the scope. At the same time, the terms such as "up", "down", "left", "right", "middle" and "one" quoted in this specification are only for the convenience of description and clarity, and are not used to limit this specification. The implementable scope of the invention, and the change or adjustment of the relative relationship thereof, shall also be regarded as the implementable scope of the present invention without substantially changing the technical content.
如图1所示,本申请第一方面提供一种植入物,所述植入物包括人工腱索1和乳头肌锚固元件2,所述人工腱索1包括人工腱索本体11及形成于所述人工腱索本体11一端的锚固瓣叶用自紧结构12,所述人工腱索本体11的另一端与乳头肌锚固元件2连接。As shown in FIG. 1 , a first aspect of the present application provides an implant, the implant includes an artificial chord 1 and a papillary muscle anchoring element 2 , and the artificial chord 1 includes an artificial chord body 11 and a The self-tightening structure 12 is used for the anchoring leaflet at one end of the artificial chord body 11 , and the other end of the artificial chord body 11 is connected to the papillary muscle anchoring element 2 .
所述锚固瓣叶用自紧结构12包括自紧线结121及瓣叶锚固环122,所述瓣叶锚固环122在所述自紧线结处闭环并锁紧。The self-tightening structure 12 for anchoring the leaflet includes a self-tightening wire knot 121 and a leaflet anchoring ring 122, and the leaflet anchoring ring 122 is closed and locked at the self-tightening wire knot.
如图2所示,所述自紧线结121为拉紧一端线头时即能锁紧的线结。所述自紧线结121选自双套结(图2a)、绳头结(图2b)、平结(图2c)、布林结(图2d)。所述自紧线结121优选为绳头结。绳头结打结方法简单、快速,易于实现。As shown in FIG. 2 , the self-tightening wire knot 121 is a wire knot that can be locked when one end of the wire end is tightened. The self-tightening thread knot 121 is selected from the group consisting of double bar knot (FIG. 2a), rope knot (FIG. 2b), flat knot (FIG. 2c), and Bollinger knot (FIG. 2d). The self-tightening knot 121 is preferably a rope knot. The rope knot knotting method is simple, fast and easy to implement.
所述自紧线结121通过缝线的不同缠绕方式,实现拉紧一端线头时即可锁紧线结。The self-tightening knot 121 realizes that the knot can be locked when one end of the thread is tightened through different winding methods of the suture.
所述自紧线结121及瓣叶锚固环122可以与人工腱索本体11成一体式结构,也可以是相连接的三个独立结构,还可以是人工腱索本体11与瓣叶锚固环122成一体式结构,所述自紧线结为利用单独的缝线形成用于锁紧瓣叶锚固环122的线结。The self-tightening knot 121 and the leaflet anchoring ring 122 can be an integral structure with the artificial chord body 11, or can be three independent structures connected, or can be the artificial chord body 11 and the leaflet anchoring ring 122. As a one-piece construction, the self-tightening knot is a knot for locking the leaflet anchoring ring 122 with separate sutures.
在一较佳实施例中,所述自紧线结121及瓣叶锚固环122与人工腱索本体11为一体式结构。所述利用人工腱索1自身缠绕成结避免在体内使用过多的缝线,同时易于控制、避免线结松动,还可提高操作速度。In a preferred embodiment, the self-tightening wire knot 121 and the leaflet anchoring ring 122 and the artificial chord body 11 are integral structures. The artificial chordae 1 is wound into a knot by itself to avoid using too many sutures in the body, and at the same time, it is easy to control, avoid the loosening of the knot, and can also improve the operation speed.
在如图1所示的实施方式中,所述植入物还包括垫片,所述瓣叶锚固环122贯穿所述垫片3。In the embodiment shown in FIG. 1 , the implant further includes a spacer, and the leaflet anchoring ring 122 penetrates the spacer 3 .
在一种实施方式中,所述垫片3包括第一垫片31和/或第二垫片32,所述瓣叶锚固环122与所述第一垫片31和/或第二垫片32相配合并经所述自紧线结121锁紧形成瓣叶锚固结构。In one embodiment, the spacer 3 includes a first spacer 31 and/or a second spacer 32, the leaflet anchoring ring 122 and the first spacer 31 and/or the second spacer 32 The valve leaflet anchoring structure is formed by matching and locking through the self-tightening wire knot 121 .
在一种实施方式中,所述第一垫片31为薄片结构。所述第一垫片31的厚度为0.1-2mm,优选0.3-1mm。In one embodiment, the first gasket 31 is a thin sheet structure. The thickness of the first gasket 31 is 0.1-2 mm, preferably 0.3-1 mm.
第一垫片31的形状可选自多边形、圆形、椭圆形,优选四边形及椭圆形。当第一垫片31的形状为四边形时,四边形的长度为1-10mm,优选为2-4mm,宽度为1-4mm,优选为1-2mm。当第一垫片31的形状为椭圆形时,椭圆形长轴为1-10mm,优选为2-4mm,短轴为1-4mm,优选为1-2mm。The shape of the first gasket 31 can be selected from polygonal, circular, oval, preferably quadrilateral and oval. When the shape of the first gasket 31 is a quadrilateral, the length of the quadrilateral is 1-10 mm, preferably 2-4 mm, and the width is 1-4 mm, preferably 1-2 mm. When the shape of the first gasket 31 is an ellipse, the long axis of the ellipse is 1-10 mm, preferably 2-4 mm, and the short axis is 1-4 mm, preferably 1-2 mm.
所述第二垫片32为薄片结构。所述第二垫片32的厚度为0.1-2mm,优选为0.3-1mm。The second gasket 32 is a thin sheet structure. The thickness of the second gasket 32 is 0.1-2 mm, preferably 0.3-1 mm.
所述第二垫片32的形状可选多边形、圆形、椭圆形,优选四边形及椭圆形。The shape of the second gasket 32 may be polygonal, circular or oval, preferably quadrilateral or oval.
当所述第二垫片32的形状为四边形时,四边形长度为1-10mm,优选为2-4mm,宽度为 1-4mm,优选为1-2mm。当所述第二垫片32的形状为椭圆形时,椭圆形长轴为1-10mm,优选为2-4mm,短轴为1-4mm,优选为1-2mm。When the shape of the second gasket 32 is quadrilateral, the quadrilateral length is 1-10mm, preferably 2-4mm, and the width is 1-4mm, preferably 1-2mm. When the shape of the second gasket 32 is an ellipse, the long axis of the ellipse is 1-10 mm, preferably 2-4 mm, and the short axis is 1-4 mm, preferably 1-2 mm.
第一垫片31和第二垫片32的材质可选用聚四氟乙烯(PTFE)、膨体聚四氟乙烯(EPTFE)、聚对苯二甲酸乙二醇酯(PET)、涤纶、毛毡、网状金属丝编织等。第一垫片31的材质优选为膨体聚四氟乙烯及聚对苯二甲酸乙二醇酯。The materials of the first gasket 31 and the second gasket 32 can be selected from polytetrafluoroethylene (PTFE), expanded polytetrafluoroethylene (EPTFE), polyethylene terephthalate (PET), polyester, felt, Mesh wire weaving, etc. The material of the first gasket 31 is preferably expanded polytetrafluoroethylene and polyethylene terephthalate.
第一垫片31和第二垫片32的结构、形状和材料可以相同,也可以不同,两者可以单独使用,也可以配合使用。第一垫片31和第二垫片32起到降低瓣叶局部牵拉应力、加速内皮化,增加锚固稳定性的作用。The structures, shapes and materials of the first gasket 31 and the second gasket 32 may be the same or different, and the two may be used alone or in combination. The first washer 31 and the second washer 32 play the roles of reducing the local traction stress of the valve leaflet, accelerating endothelialization, and increasing the anchoring stability.
如图3所示,所述乳头肌锚固元件2选自螺旋(图3a)、倒刺(图3b)、类船锚结构(图3c)。所述乳头肌锚固元件2可嵌入心肌组织,作为人工腱索1与心肌连接的固定机构。As shown in Fig. 3, the papillary muscle anchoring element 2 is selected from the group consisting of helix (Fig. 3a), barb (Fig. 3b), and anchor-like structure (Fig. 3c). The papillary muscle anchoring element 2 can be embedded in myocardial tissue as a fixing mechanism for connecting the artificial chordae tendineae 1 with the myocardium.
本发明第二方面提供一种用于形成所述植入物的组件,所述组件包括人工腱索线体和乳头肌锚固元件2,所述人工腱索线体包括引导用连接段、人工腱索本体段及自紧结构形成用线段,所述人工腱索线体适于形成所述植入物中的人工腱索1。A second aspect of the present invention provides an assembly for forming the implant, the assembly including an artificial chord body and a papillary muscle anchoring element 2, the artificial chord body including a connecting segment for guiding, an artificial tendon A cable body segment and a wire segment for forming a self-tightening structure, the artificial tendon cable body is suitable for forming the artificial tendon cable 1 in the implant.
具体的,所述组件还包括垫片,所述瓣叶锚固环122贯穿所述垫片3。Specifically, the assembly further includes a gasket, and the leaflet anchoring ring 122 penetrates the gasket 3 .
所述垫片至少设有一个。在一种实施方式中,所述垫片3包括第一垫片31和第二垫片32,所述瓣叶锚固环122与所述第一垫片31和第二垫片32相配合并经所述自紧线结121锁紧形成瓣叶锚固结构。At least one of the spacers is provided. In one embodiment, the gasket 3 includes a first gasket 31 and a second gasket 32, and the leaflet anchoring ring 122 is matched with the first gasket 31 and the second gasket 32 and passed through the The self-tightening knot 121 is locked to form a leaflet anchoring structure.
所述人工腱索线体选自线材。具体的,所述线材符合YY 0167-2020标准要求。The artificial tendon cable body is selected from wires. Specifically, the wire meets the requirements of the YY 0167-2020 standard.
一般的,所述线材的直径规格可选5-0、4-0、3-0、2-0/T、2-0。所述线材的直径优选为3-0、2-0。临床数据表明3-0、2-0直径的线材更接近腱索的使用需求。Generally, the diameter specifications of the wire can be selected from 5-0, 4-0, 3-0, 2-0/T, and 2-0. The diameter of the wire is preferably 3-0, 2-0. Clinical data show that 3-0 and 2-0 diameter wires are closer to the needs of the chordae tendineae.
所述线材的结构可为单股或多股编织。所述线材的结构优选为单股。单股的结构更稳定,多股有抽丝,扭转或扭曲的风险。The structure of the wire can be single or multiple braided. The structure of the wire is preferably a single strand. Single strands are more stable in structure, and multiple strands run the risk of snagging, twisting or twisting.
所述线材的材质可选聚四氟乙烯(PTFE)、膨体聚四氟乙烯(EPTFE)、聚对苯二甲酸乙二醇酯(PET)、超高分子量聚乙烯(UHMWPE)、桑蚕丝、尼龙、棉等。所述线材的材质优选为聚四氟乙烯(PTFE)、膨体聚四氟乙烯(EPTFE)。对此,本发明不做特殊的限定。The material of the wire can be selected from polytetrafluoroethylene (PTFE), expanded polytetrafluoroethylene (EPTFE), polyethylene terephthalate (PET), ultra-high molecular weight polyethylene (UHMWPE), mulberry silk, Nylon, cotton, etc. The material of the wire rod is preferably polytetrafluoroethylene (PTFE) or expanded polytetrafluoroethylene (EPTFE). In this regard, the present invention does not make any special limitation.
较佳的,所述引导用连接段的作用是输送时可以辅助引导人工腱索本体段及自紧结构形成用线段进行移动,辅助完毕后引导用连接段被切割掉不留在体内。优选地,引导用连接段可以实现DSA下显影,可以选择在引导用连接段添加显影剂,或者缠绕显影丝,或者可拆卸连接的连接件采用可显影的材料,如黄金、铂金、PtW合金、钽或PtIr合金等。以上各段的界限并无明显划分,引导用连接段起到引导作用即可,自紧结构形成用线段对应植入物中形 成锚固瓣叶用自紧结构12的线段,而人工腱索本体段则对应植入物中作为人工腱索本体的线段。Preferably, the guiding connecting segment is used to assist in guiding the movement of the artificial chord body segment and the line segment for forming the self-tightening structure during transportation. Preferably, the connecting section for guiding can realize development under DSA, and you can choose to add developer to the connecting section for guiding, or wrap the developing wire, or the detachable connecting piece is made of developable materials, such as gold, platinum, PtW alloy, Tantalum or PtIr alloy, etc. The boundaries of the above segments are not clearly demarcated, and the guiding connecting segment can play a guiding role. The line segment for forming the self-tightening structure corresponds to the line segment for forming the self-tightening structure 12 for anchoring the leaflet in the implant, while the main segment of the artificial chordae tendineae Then it corresponds to the line segment in the implant as the body of the artificial chordae tendineae.
所述引导用连接段、人工腱索本体段与自紧结构形成用线段可以是一条线材的不同线段,也可以是三条线材,还可以是两条线材,此时引导用连接段和人工腱索本体段为一条线材,自紧结构形成用线段为另一条线材。当然,也可以有其他的组合,只要可以形成所述植入物即可。The guiding connecting section, the artificial tendon body section and the self-tightening structure forming line can be different sections of one wire, three wires, or two wires. At this time, the guiding connecting section and the artificial tendon are The body segment is a wire, and the wire segment for forming the self-tightening structure is another wire. Of course, other combinations are possible as long as the implant can be formed.
如图3所示,所述乳头肌锚固元件2选自螺旋(图3a)、倒刺(图3b)、类船锚结构(图3c)。所述乳头肌锚固元件2可嵌入心肌组织,作为人工腱索1与心肌连接的固定机构。As shown in Fig. 3, the papillary muscle anchoring element 2 is selected from the group consisting of helix (Fig. 3a), barb (Fig. 3b), and anchor-like structure (Fig. 3c). The papillary muscle anchoring element 2 can be embedded in myocardial tissue as a fixing mechanism for connecting the artificial chordae tendineae 1 with the myocardium.
如图4所示,本发明第三方面提供一种介入人工腱索修复装置,所述修复装置包括植入物、连接导丝41和输送系统5,所述连接导丝41设于输送系统5内,所述输送系统5设有适配所述组件中人工腱索线体的通道。As shown in FIG. 4 , a third aspect of the present invention provides an interventional artificial chord repair device, the repair device includes an implant, a connecting guide wire 41 and a delivery system 5 , and the connecting guide wire 41 is provided in the delivery system 5 . Inside, the delivery system 5 is provided with a channel adapted to the artificial tendon cord body in the assembly.
在一种实施方式中,所述连接导丝41选自金属丝。较佳的,选自弹性并具有良好支撑性能的金属丝。所述连接导丝41的直径为0.2-1.5mm,优选为0.5-1.0mm。所述连接导丝41的结构可为单股、芯轴加内外弹簧等结构,优选单股。金属丝的材质可选镍钛合金、不锈钢、钛合金,优选为镍钛合金。连接导丝41的头端为尖锐针头形状。In one embodiment, the connecting guide wire 41 is selected from metal wires. Preferably, it is selected from metal wires that are elastic and have good supporting properties. The diameter of the connecting guide wire 41 is 0.2-1.5 mm, preferably 0.5-1.0 mm. The structure of the connecting guide wire 41 can be a single strand, a mandrel plus inner and outer springs, etc., preferably a single strand. The material of the metal wire can be selected from nickel-titanium alloy, stainless steel, titanium alloy, preferably nickel-titanium alloy. The head end of the connecting guide wire 41 is in the shape of a sharp needle.
进一步的,在介入人工腱索修复装置植入时,连接导丝41与引导用连接段的自由端可拆卸连接。所述可拆卸连接方式可以为卡扣、磁吸、榫卯、耦合等,本发明不做特殊的限定。Further, when the interventional artificial chord repair device is implanted, the connecting guide wire 41 is detachably connected to the free end of the connecting segment for guiding. The detachable connection method may be a snap, magnetic attraction, tenon and tenon, coupling, etc., which is not limited in the present invention.
在如图4所示的实施例中,输送系统5包括第一夹头51和第二夹头52,第一夹头51内设有U型通道511,第二夹头52设有中心通道521、第一侧壁通道522及第二侧壁通道523,所述第一侧壁通道522一端、第二侧壁通道523一端与中心通道521连通,在使用状态下,第一侧壁通道522另一端、第二侧壁通道523另一端分别与U型通道511的两个开口对齐。In the embodiment shown in FIG. 4 , the delivery system 5 includes a first chuck 51 and a second chuck 52 , the first chuck 51 is provided with a U-shaped channel 511 , and the second chuck 52 is provided with a central channel 521 , the first side wall channel 522 and the second side wall channel 523, one end of the first side wall channel 522 and one end of the second side wall channel 523 are communicated with the central channel 521. In the use state, the first side wall channel 522 is another One end and the other end of the second sidewall channel 523 are aligned with the two openings of the U-shaped channel 511 respectively.
较佳的,在使用状态下,第一夹头51和第二夹头52分别设于瓣叶6两侧相同位置,即第一夹头51和第二夹头52可相隔瓣叶6对齐。Preferably, in the use state, the first chuck 51 and the second chuck 52 are respectively set at the same position on both sides of the leaflet 6 , that is, the first chuck 51 and the second chuck 52 can be aligned with the leaflet 6 apart.
具体的,第一夹头51和第二夹头52可相对移动,二者相互靠近时夹持瓣叶。Specifically, the first chuck 51 and the second chuck 52 can move relative to each other, and when they are close to each other, they clamp the valve leaflet.
具体的,当第一夹头51和第二夹头52靠近时,第一侧壁通道522的一端、第二侧壁通道523的一端分别与U型管道511的两个开口对齐后,连接导丝41可穿过第二垫片32、瓣叶6、第一垫片31后进入U型管道511。Specifically, when the first collet 51 and the second collet 52 are close to each other, one end of the first side wall channel 522 and one end of the second side wall channel 523 are respectively aligned with the two openings of the U-shaped pipe 511, and the connecting guide The wire 41 can enter the U-shaped channel 511 after passing through the second gasket 32 , the valve leaflet 6 , and the first gasket 31 .
所述介入人工腱索修复装置使用前,第一垫片31预置于第一夹头51中U形通道511与瓣叶之间,第二垫片32预置于第二夹头52中中心通道521、第一侧壁通道522或第二侧壁通道523与瓣叶之间,连接导丝41预置于中心通道521中;将预置好的连接导丝41斜插入 第一侧壁通道522;自紧线结121缠绕在连接导丝41上,连接段置于第二侧壁通道523中。所述介入人工腱索修复装置用于形成所述植入物。Before the interventional artificial chord repair device is used, the first gasket 31 is pre-placed between the U-shaped channel 511 and the valve leaflet in the first collet 51 , and the second gasket 32 is pre-placed in the center of the second collet 52 . Between the channel 521, the first side wall channel 522 or the second side wall channel 523 and the valve leaflets, the connecting guide wire 41 is pre-placed in the central channel 521; the preset connecting guide wire 41 is obliquely inserted into the first side wall channel 522; the self-tightening wire knot 121 is wound on the connecting guide wire 41, and the connecting segment is placed in the second side wall channel 523. The interventional artificial chordae repair device is used to form the implant.
如图5所示,所述植入物的形成方法包括以下步骤:As shown in Figure 5, the method for forming the implant includes the following steps:
1)如图5a,人工腱索线体的部分线段缠绕连接导丝41;当第一夹头51和第二夹头52夹紧,第一侧壁通道522的开口、第二侧壁通道523的开口分别与U型通道511的两个开口对齐后,沿图示箭头方向推动连接导丝41依次穿透第二垫片32、瓣叶6、第一垫片31,进入U型通道511;1) As shown in Fig. 5a, a part of the artificial tendon cable body is wound around the connecting guide wire 41; when the first collet 51 and the second collet 52 are clamped, the opening of the first side wall channel 522 and the second side wall channel 523 After the openings of the valve are aligned with the two openings of the U-shaped channel 511, the connecting guide wire 41 is pushed in the direction of the arrow shown in the figure to penetrate the second gasket 32, the valve leaflet 6, the first gasket 31 in turn, and enter the U-shaped channel 511;
2)如图5b,继续沿图示箭头方向推动连接导丝41,连接导丝41进入U型通道511,与引导用连接段相连接;可选的,连接导丝41在U型通道511内依次穿透第一垫片31、瓣叶6、第二垫片3后再与引导用连接段相连接;2) As shown in Figure 5b, continue to push the connecting guide wire 41 in the direction of the arrow shown in the figure, the connecting guide wire 41 enters the U-shaped channel 511, and is connected with the connecting section for guiding; optionally, the connecting guide wire 41 is in the U-shaped channel 511. After penetrating the first gasket 31, the valve leaflet 6 and the second gasket 3 in sequence, they are connected with the connecting section for guiding;
3)如图5c,沿图示箭头方向回撤连接导丝41,连接导丝41会带动引导用连接段、人工腱索本体段、自紧结构形成用线段依次穿过第二垫片32、瓣叶6、第一垫片31后,自紧结构形成用线段在自紧线结处闭环形成瓣叶锚固环122;3) As shown in Fig. 5c, the connecting guide wire 41 is withdrawn in the direction of the arrow shown in the figure, and the connecting guide wire 41 will drive the connecting section for guiding, the main body section of the artificial chordae tendineae, and the line section for forming the self-tightening structure to pass through the second gasket 32, After the valve leaflet 6 and the first gasket 31, the self-tightening structure forming line segment is closed at the self-tightening wire knot to form the valve leaflet anchoring ring 122;
4)如图5d,继续回撤连接导丝41,使人工腱索线体形成自紧线结121;4) As shown in Figure 5d, continue to withdraw and connect the guide wire 41, so that the artificial tendon cable body forms a self-tightening knot 121;
5)如图5e,取出第一夹头51和第二夹头52,收紧自紧线结121;5) As shown in Figure 5e, take out the first chuck 51 and the second chuck 52, and tighten the self-tightening knot 121;
6)将人工腱索线体穿过乳头肌锚固元件2,使二者活动连接,调整人工腱索本体的长度,剪除引导用连接段,将人工腱索本体与乳头肌锚固元件2固定连接,即形成植入物。6) passing the artificial tendon cord body through the papillary muscle anchoring element 2, making the two movably connected, adjusting the length of the artificial tendon cord body, cutting off the guiding connecting section, and fixing the artificial tendon cord body and the papillary muscle anchoring element 2, The implant is formed.
在如图6所示的实施方式中,所述介入人工腱索修复装置还包括辅助连接导丝42和辅助连接线43,所述辅助连接导丝42与引导用连接段可拆卸连接,所述辅助连接线43设于U型通道511内,一端与引导用连接段和/或辅助连接导丝42可拆卸连接,另一端与连接导丝41可拆卸连接。辅助连接导丝42和辅助连接线43的设置可以更快速的完成植入。In the embodiment shown in FIG. 6 , the interventional artificial chord repair device further includes an auxiliary connecting guide wire 42 and an auxiliary connecting wire 43 , and the auxiliary connecting guide wire 42 is detachably connected to the connecting segment for guiding. The auxiliary connecting wire 43 is arranged in the U-shaped channel 511 , one end is detachably connected to the guiding connecting section and/or the auxiliary connecting wire 42 , and the other end is detachably connected to the connecting wire 41 . The setting of the auxiliary connecting guide wire 42 and the auxiliary connecting wire 43 can complete the implantation more quickly.
所述可拆卸连接选自卡扣、磁吸、榫卯、耦合等方式。辅助连接导丝42的作用是通过一端连接的引导用连接段,进而引导自紧结构形成用线段及人工腱索本体段进入U型通道511。The detachable connection is selected from snap, magnetic attraction, tenon and tenon, coupling and the like. The function of the auxiliary connection guide wire 42 is to guide the wire segment for forming the self-tightening structure and the main body segment of the artificial chordae tendineae into the U-shaped channel 511 through the guiding connection segment connected at one end.
如图6所示,辅助连接线43包括第一连接端431及第二连接端432,植入时,第一连接端431与连接导丝41连接,第二连接端432与辅助连接导丝42一端连接。较佳的,第一连接端431与连接导丝41之间的连接、第二连接端432与辅助连接导丝42之间的连接均为可拆卸连接。辅助连接线43的作用是可以帮助连接导丝41实现与引导用连接段的连接。其中,辅助连接线43与引导用连接段为可拆卸连接。所述可拆卸连接选自卡扣、磁吸、榫卯、耦合等方式。辅助连接线43可以实现DSA下显影,可以选择在辅助连接线43添加显影剂,或者缠绕金属丝,或者辅助连接线43两端的连接结构采用金属材料。As shown in FIG. 6 , the auxiliary connecting wire 43 includes a first connecting end 431 and a second connecting end 432 . During implantation, the first connecting end 431 is connected to the connecting guide wire 41 , and the second connecting end 432 is connected to the auxiliary connecting guide wire 42 . connected at one end. Preferably, the connection between the first connection end 431 and the connection guide wire 41 and the connection between the second connection end 432 and the auxiliary connection guide wire 42 are all detachable connections. The function of the auxiliary connecting wire 43 is to help the connecting guide wire 41 to realize the connection with the connecting segment for guiding. Wherein, the auxiliary connecting wire 43 is detachably connected with the guiding connecting section. The detachable connection is selected from snap, magnetic attraction, tenon and tenon, coupling and the like. The auxiliary connecting wire 43 can realize development under DSA, and a developer can be added to the auxiliary connecting wire 43, or a metal wire can be wound, or the connection structure at both ends of the auxiliary connecting wire 43 can be made of metal material.
所述介入人工腱索修复装置使用前,将连接导丝41及辅助连接导丝42预设于中心通道521内;U型通道511内预置辅助连接线43。Before the interventional artificial chord repair device is used, the connecting guide wire 41 and the auxiliary connecting guide wire 42 are preset in the central channel 521 ; the auxiliary connecting wire 43 is preset in the U-shaped channel 511 .
如图7所示,所述植入物的形成方法包括以下步骤:As shown in Figure 7, the method for forming the implant includes the following steps:
1)如图7a所示,人工腱索线体的部分线段缠绕连接导丝41;当第一夹头51和第二夹头52夹紧,第一侧壁通道522的开口、第二侧壁通道523的开口分别与U型通道511的两个开口对齐后,沿图示箭头方向推动连接导丝41进入U型通道511后与第二连接端432连接;同时,沿图示箭头方向推动辅助连接导丝42进入U型通道511后与第一连接端431相连接,此时引导用连接段被辅助连接导丝42携带着同时进入U型通道511与第一连接端431连接。可选的,连接导丝41和辅助连接导丝42均依次穿透第二垫片32、瓣叶6、第一垫片31后进入U型通道511。1) As shown in Fig. 7a, part of the artificial tendon cable body is wound around the connecting guide wire 41; when the first chuck 51 and the second chuck 52 are clamped, the opening of the first side wall channel 522, the second side wall After the openings of the channel 523 are respectively aligned with the two openings of the U-shaped channel 511, push the connecting guide wire 41 into the U-shaped channel 511 in the direction of the arrow shown in the figure and then connect with the second connection end 432; at the same time, push the auxiliary wire 41 in the direction of the arrow in the figure. The connecting guide wire 42 enters the U-shaped channel 511 and is connected to the first connecting end 431 . At this time, the guiding connecting section is carried by the auxiliary connecting guide wire 42 and enters the U-shaped channel 511 to connect with the first connecting end 431 . Optionally, the connecting guide wire 41 and the auxiliary connecting guide wire 42 both penetrate the second gasket 32 , the valve leaflet 6 , and the first gasket 31 in sequence and then enter the U-shaped channel 511 .
2)如图7b所示,沿图示箭头方向回撤连接导丝41及辅助连接导丝42,此时辅助连接导丝42与第二连接端432脱离,第二连接端432与引导用连接段保持可拆卸连接。2) As shown in Figure 7b, withdraw the connecting guide wire 41 and the auxiliary connecting guide wire 42 in the direction of the arrow shown in the figure, at this time, the auxiliary connecting guide wire 42 is separated from the second connecting end 432, and the second connecting end 432 is connected with the guide Segments remain detachably attached.
3)如图7c,沿图示箭头方向回撤辅助连接导丝42,辅助连接导丝42撤出后不再使用,同时回撤连接导丝41,连接导丝41带动辅助连接线43运动,辅助连接线43带动引导用连接段、人工腱索本体段、自紧结构形成用线段移动,自紧结构形成用线段在自紧线结处闭环形成瓣叶锚固环122。可选的,辅助连接线43带动引导用连接段、人工腱索本体段、自紧结构形成用线段移动依次穿过第一垫片31、瓣叶6、第二垫片32。3) As shown in Figure 7c, the auxiliary connection guide wire 42 is withdrawn in the direction of the arrow shown in the figure. After the auxiliary connection guide wire 42 is withdrawn, it is no longer used. At the same time, the connection guide wire 41 is withdrawn, and the connection guide wire 41 drives the auxiliary connection wire 43 to move. The auxiliary connecting wire 43 drives the guiding connecting section, the artificial chordae body section, and the self-tightening structure forming section to move, and the self-tightening structure forming section closes the loop at the self-tightening knot to form the leaflet anchoring ring 122 . Optionally, the auxiliary connecting wire 43 drives the connecting segment for guiding, the body segment of the artificial chordae tendineae, and the segment for forming the self-tightening structure to move through the first gasket 31 , the valve leaflet 6 , and the second gasket 32 in sequence.
4)继续回撤连接导丝41,使引导用连接段、人工腱索本体段穿过自紧线结121。4) Continue to withdraw the connecting guide wire 41, so that the connecting section for guiding and the body section of the artificial chordae tendineae pass through the self-tightening knot 121.
5)取出第一夹头51和第二夹头52,收紧自紧线结121;5) Take out the first chuck 51 and the second chuck 52, and tighten the self-tightening knot 121;
6)将人工腱索线体穿过乳头肌锚固元件2,使二者活动连接,调整人工腱索本体的长度,剪除引导用连接段后,将人工腱索本体与乳头肌锚固元件2固定连接。6) Pass the artificial chord body through the papillary muscle anchoring element 2, make the two movably connected, adjust the length of the artificial chord body, cut off the guiding connecting section, and connect the artificial chord body and the papillary muscle anchoring element 2 fixedly .
本申请第四方面提供所述植入物、所述组件或所述介入人工腱索修复装置在制备治疗二尖瓣反流产品中的用途。A fourth aspect of the present application provides the use of the implant, the assembly or the interventional artificial chordae tendineae repair device in the manufacture of a product for treating mitral valve regurgitation.
如图8所示,所述介入人工腱索修复装置在使用时的步骤如下:输送系统5由房间隔通过通用鞘管进入心房(图8a);推送输送系统5,在超声及DSA医学影像设备辅助下完成瓣叶夹持(图8b);释放垫片3和瓣叶用自紧结构12,回拉输送系统5,回撤人工腱索1(图8c);由输送系统5将乳头肌锚固元件2锚定于左心室心肌层(图8d);回撤输送系统5,此时乳头肌锚固元件2与引导用连接段的一端连接,通过超声影像辅助调整人工腱索长度,确保无反流(图8e)。调整好长度后,剪掉引导用连接段,植入物在心脏内的最终状态如图 8f所示。As shown in FIG. 8 , the steps of using the interventional artificial chordae tendineae repair device are as follows: the delivery system 5 enters the atrium from the atrial septum through the universal sheath ( FIG. 8 a ); Complete valve leaflet clamping with assistance (Figure 8b); release gasket 3 and valve leaflet with self-tightening structure 12, pull back delivery system 5, and withdraw artificial chordae tendineae 1 (Figure 8c); use delivery system 5 to anchor papillary muscle Element 2 is anchored in the myocardium of the left ventricle (Fig. 8d); the delivery system 5 is withdrawn. At this time, the papillary muscle anchoring element 2 is connected to one end of the connecting segment for guidance, and the length of the artificial chordae tendineae is adjusted by ultrasound imaging to ensure no reflux (Fig. 8e). After adjusting the length, cut off the connecting segment for guiding, and the final state of the implant in the heart is shown in Fig. 8f.
所述植入物或所述介入人工腱索修复装置的使用可以通过介入方式完成人工腱索与瓣叶的固定,无需开胸、手术创伤小、患者恢复快。且固定牢靠,不易产生瓣叶撕裂,同时有利于植入物的快速内皮化,有利于创面的愈合。The use of the implant or the interventional artificial chordae tendineae repair device can complete the fixation of the artificial chordae tendineae and valve leaflets through an interventional manner, without the need for thoracotomy, with less surgical trauma and quicker recovery of the patient. And the fixation is firm, the valve leaflet is not easily torn, and at the same time, it is conducive to the rapid endothelialization of the implant and the healing of the wound surface.
综上所述,本发明有效克服了现有技术中的种种缺点而具高度产业利用价值。To sum up, the present invention effectively overcomes various shortcomings in the prior art and has high industrial utilization value.
上述实施例仅例示性说明本发明的原理及其功效,而非用于限制本发明。任何熟悉此技术的人士皆可在不违背本发明的精神及范畴下,对上述实施例进行修饰或改变。因此,举凡所属技术领域中具有通常知识者在未脱离本发明所揭示的精神与技术思想下所完成的一切等效修饰或改变,仍应由本发明的权利要求所涵盖。The above-mentioned embodiments merely illustrate the principles and effects of the present invention, but are not intended to limit the present invention. Anyone skilled in the art can modify or change the above embodiments without departing from the spirit and scope of the present invention. Therefore, all equivalent modifications or changes made by those with ordinary knowledge in the technical field without departing from the spirit and technical idea disclosed in the present invention should still be covered by the claims of the present invention.

Claims (19)

  1. 一种植入物,其特征在于,所述植入物包括人工腱索(1)和乳头肌锚固元件(2),所述人工腱索(1)包括人工腱索本体(11)及形成于所述人工腱索本体(11)一端的锚固瓣叶用自紧结构(12),所述人工腱索本体(11)的另一端与乳头肌锚固元件(2)连接。An implant, characterized in that the implant comprises an artificial chordae tendineae (1) and a papillary muscle anchoring element (2), the artificial chordae tendineae (1) comprising an artificial chordae tendineae body (11) and a A self-tightening structure (12) is used for the anchoring valve leaflet at one end of the artificial chord body (11), and the other end of the artificial chord body (11) is connected with the papillary muscle anchoring element (2).
  2. 根据权利要求1所述的植入物,其特征在于,所述锚固瓣叶用自紧结构(12)包括自紧线结(121)及瓣叶锚固环(122),所述瓣叶锚固环(122)在所述自紧线结处闭环并锁紧。The implant according to claim 1, characterized in that the self-tightening structure (12) for anchoring the leaflet comprises a self-tightening wire knot (121) and a leaflet anchoring ring (122), the leaflet anchoring ring (122) Close the loop and lock at the self-tightening wire knot.
  3. 根据权利要求2所述的植入物,其特征在于,所述自紧线结(121)选自布林结、绳头结、双套结、平结。The implant according to claim 2, characterized in that, the self-tightening knot (121) is selected from the group consisting of a Bollinger knot, a rope knot, a double bar knot, and a flat knot.
  4. 根据权利要求2所述的植入物,其特征在于,所述植入物还包括垫片(3),所述瓣叶锚固环(122)贯穿所述垫片(3)。The implant according to claim 2, characterized in that the implant further comprises a spacer (3), and the leaflet anchoring ring (122) penetrates the spacer (3).
  5. 根据权利要求4所述的植入物,其特征在于,所述垫片包括第一垫片(31)和/或第二垫片(32),所述瓣叶锚固环(122)与所述第一垫片(31)和/或第二垫片(32)相配合并经所述自紧线结(121)锁紧形成瓣叶锚固结构。The implant according to claim 4, wherein the spacer comprises a first spacer (31) and/or a second spacer (32), and the leaflet anchoring ring (122) is associated with the The first gasket (31) and/or the second gasket (32) are matched and locked through the self-tightening wire knot (121) to form a leaflet anchoring structure.
  6. 根据权利要求1所述的植入物,其特征在于,所述乳头肌锚固元件(2)呈螺旋状、设有倒刺的柱状或类船锚状。The implant according to claim 1, characterized in that the papillary muscle anchoring element (2) is in the shape of a helix, a barb-shaped column or a ship-anchor-like shape.
  7. 一种用于形成权利要求1-6任一所述植入物的组件,其特征在于,所述组件包括人工腱索线体和乳头肌锚固元件(2),所述人工腱索线体包括引导用连接段、人工腱索本体段及自紧结构形成用线段,所述人工腱索线体适于形成权利要求1-6任一所述植入物中的人工腱索(1),可选的,所述组件还包括垫片。An assembly for forming the implant according to any one of claims 1-6, characterized in that the assembly comprises an artificial chord body and a papillary muscle anchoring element (2), the artificial chord body comprising A guiding connecting segment, an artificial chord body segment and a line segment for forming a self-tightening structure, the artificial chord body is suitable for forming the artificial chord (1) in the implant according to any one of claims 1-6, and can be Optionally, the assembly further includes a gasket.
  8. 根据权利要求7所述的组件,其特征在于,所述人工腱索线体选自线材。The assembly of claim 7, wherein the artificial tendon cable body is selected from wires.
  9. 根据权利要求7所述的组件,其特征在于,所述垫片至少设有一个,优选的,所述垫片包括第一垫片(31)和第二垫片(32)。The assembly according to claim 7, characterized in that at least one gasket is provided, preferably, the gasket includes a first gasket (31) and a second gasket (32).
  10. 根据权利要求7所述的组件,其特征在于,所述乳头肌锚固元件(2)呈螺旋状、设有倒刺的柱状或类船锚状。The assembly according to claim 7, characterized in that the papillary muscle anchoring element (2) is in the shape of a helical, a barb-shaped column or a ship-anchor-like shape.
  11. 根据权利要求7所述的组件,其特征在于,所述引导用连接段的自由端设有磁块、榫卯结构或卡扣结构;优选的,所述植入物形成后,所述引导用连接段被剪切去除。The assembly according to claim 7, wherein the free end of the guiding connecting section is provided with a magnetic block, a tenon-and-mortise structure or a buckle structure; preferably, after the implant is formed, the guiding The connecting segment is cut and removed.
  12. 一种介入人工腱索修复装置,其特征在于,所述修复装置包括权利要求7-11任一所述的组件、连接导丝(41)和输送系统(5),所述连接导丝(41)设于输送系统(5)内,所述输送系统(5)设有适配所述组件中人工腱索线体的通道。An interventional artificial chord repair device, characterized in that the repair device comprises the component according to any one of claims 7-11, a connecting guide wire (41) and a delivery system (5), the connecting guide wire (41) ) is arranged in a delivery system (5), the delivery system (5) is provided with a channel adapted to the artificial tendon cord body in the assembly.
  13. 根据权利要求12所述的介入人工腱索修复装置,其特征在于,所述连接导丝(41)选 自金属丝;所述连接导丝(41)与引导用连接段的自由端可拆卸连接。The interventional artificial chord repair device according to claim 12, wherein the connecting guide wire (41) is selected from metal wires; the connecting guide wire (41) is detachably connected to the free end of the connecting segment for guiding .
  14. 根据权利要求12所述的介入人工腱索修复装置,其特征在于,输送系统(5)包括第一夹头(51)和第二夹头(52),第一夹头(51)内设有U型通道(511),第二夹头(52)设有中心通道(521)、第一侧壁通道(522)及第二侧壁通道(523),所述第一侧壁通道(522)一端、第二侧壁通道(523)一端均与中心通道(521)连通,在使用状态下,第一侧壁通道(522)另一端、第二侧壁通道(523)另一端分别与U型通道(511)的两个开口对齐。The interventional artificial chord repair device according to claim 12, wherein the delivery system (5) comprises a first chuck (51) and a second chuck (52), and the first chuck (51) is provided with a U-shaped channel (511), the second chuck (52) is provided with a central channel (521), a first side wall channel (522) and a second side wall channel (523), the first side wall channel (522) One end and one end of the second side wall channel (523) are both communicated with the central channel (521). The two openings of the channel (511) are aligned.
  15. 根据权利要求14所述的介入人工腱索修复装置,其特征在于,所述介入人工腱索修复装置还包括辅助连接导丝(42)和辅助连接线(43),所述辅助连接导丝(42)与引导用连接段可拆卸连接,所述辅助连接线(43)设于所述U型通道(511)内,一端与引导用连接段和/或辅助连接导丝(42)可拆卸连接,另一端与连接导丝(41)可拆卸连接。The interventional artificial chord repair device according to claim 14, characterized in that, the interventional artificial chord repair device further comprises an auxiliary connection guide wire (42) and an auxiliary connection wire (43), the auxiliary connection guide wire ( 42) Removably connected with the connecting section for guiding, the auxiliary connecting wire (43) is provided in the U-shaped channel (511), and one end is detachably connected with the connecting section for guiding and/or the auxiliary connecting wire (42) , and the other end is detachably connected with the connecting guide wire (41).
  16. 根据权利要求13或15所述的介入人工腱索修复装置,其特征在于,所述可拆卸连接选自磁吸连接、榫卯连接或卡扣连接。The interventional artificial chord repair device according to claim 13 or 15, wherein the detachable connection is selected from a magnetic attraction connection, a tenon-and-mortise connection or a snap connection.
  17. 一种权利要求1-6任一所述植入物的形成方法,其特征在于,所述形成方法包括以下步骤:A method for forming the implant according to any one of claims 1-6, wherein the method for forming comprises the following steps:
    1)将人工腱索线体的部分线段缠绕连接导丝(41);1) winding part of the segment of the artificial tendon cable body to connect the guide wire (41);
    2)将输送系统(5)的第一夹头(51)和第二夹头(52)夹紧,以使设于第二夹头(52)上的第一侧壁通道(522)的开口、第二侧壁通道(523)的开口分别与设于第一夹头上的U型通道(511)的两个开口对齐;2) Clamp the first collet (51) and the second collet (52) of the delivery system (5), so that the opening of the first side wall channel (522) provided on the second collet (52) , the openings of the second side wall channel (523) are respectively aligned with the two openings of the U-shaped channel (511) provided on the first chuck;
    3)选自以下任一步或两步:3) Choose one or two steps from the following:
    i.沿第一侧壁通道(522)推动连接导丝(41),使连接导丝(41)进入U型通道(511),与人工腱索线体上的引导用连接段连接;i. Push the connecting guide wire (41) along the first side wall channel (522), so that the connecting guide wire (41) enters the U-shaped channel (511), and is connected with the guiding connecting segment on the artificial tendon cord body;
    ii.沿第二侧壁通道(523)推动辅助连接导丝(42)以使人工腱索线体上的引导用连接段与设于U型通道(511)内的辅助连接线(43)相连接,沿第一侧壁通道(522)推动连接导丝(41),使连接导丝(41)进入U型通道(511),与辅助连接线(43)相连接,撤出辅助连接导丝(42);ii. Push the auxiliary connection guide wire (42) along the second side wall channel (523) to make the guiding connection section on the artificial tendon cable body and the auxiliary connection wire (43) provided in the U-shaped channel (511) to be in contact with each other. To connect, push the connecting guide wire (41) along the first side wall channel (522), so that the connecting guide wire (41) enters the U-shaped channel (511), connects with the auxiliary connecting wire (43), and withdraws the auxiliary connecting guide wire (42);
    4)回撤连接导丝(41)以使人工腱索线体形成自紧线结(121)及瓣叶锚固环(122);4) withdrawing the connecting guide wire (41) so that the artificial tendon cable body forms a self-tightening knot (121) and a leaflet anchoring ring (122);
    5)继续回撤连接导丝(41),使引导用连接段、人工腱索本体段穿过自紧线结(121);5) Continue to withdraw the connecting guide wire (41), so that the connecting section for guiding and the body section of the artificial chordae tendineae pass through the self-tightening knot (121);
    6)收紧自紧线结(121);6) Tighten the self-tightening knot (121);
    7)使人工腱索线体与乳头肌锚固元件(2)活动连接,调整人工腱索本体的长度,剪除 引导用连接段,将人工腱索本体与乳头肌锚固元件2固定连接。7) make artificial chord body and papillary muscle anchoring element (2) movably connected, adjust the length of artificial chord body, cut off the guiding connection section, artificial chord body and papillary muscle anchoring element 2 are fixedly connected.
  18. 根据权利要求17所述的植入物的形成方法,其特征在于,所述形成方法还包括以下步骤:The method for forming an implant according to claim 17, wherein the forming method further comprises the steps of:
    a)在步骤2)之前将所述垫片(3)设于输送系统(5)的第一夹头(51)中U型通道(511)开口端,和/或,第二夹头(52)内第一侧壁通道(522)开口及第二侧壁通道(523)的开口端;a) Before step 2), set the gasket (3) on the open end of the U-shaped channel (511) in the first collet (51) of the delivery system (5), and/or, the second collet (52) ) in the opening of the first side wall channel (522) and the open end of the second side wall channel (523);
    b)步骤i中,沿第一侧壁通道(522)推动连接导丝(41),连接导丝(41)穿透垫片(3)后进入U型通道(511),与人工腱索线体上的引导用连接段连接;b) In step i, the connecting guide wire (41) is pushed along the first side wall channel (522), and the connecting guide wire (41) penetrates the gasket (3) and then enters the U-shaped channel (511) to connect with the artificial tendon cord. The guide on the body is connected with a connecting segment;
    c)步骤ii中,沿第二侧壁通道(523)推动辅助连接导丝(42),使其穿透垫片(3)携带引导用连接段与辅助连接线(43)相连接,沿第一侧壁通道(522)推动连接导丝(41),使连接导丝(41)穿透垫片(3)进入U型通道(511),与辅助连接线(43)相连接,撤出辅助连接导丝(42)。c) In step ii, push the auxiliary connection guide wire (42) along the second side wall channel (523), so that it penetrates the gasket (3) and carries the guiding connection section to connect with the auxiliary connection wire (43), along the second side wall channel (523) A side wall channel (522) pushes the connecting guide wire (41), so that the connecting guide wire (41) penetrates the gasket (3) into the U-shaped channel (511), connects with the auxiliary connecting wire (43), and withdraws the auxiliary connecting wire (41). Connect the guide wire (42).
  19. 权利要求1-6任一所述的植入物、权利要求7-11任一所述的组件或权利要求12-16任一所述的介入人工腱索修复装置在制备治疗二尖瓣反流产品中的用途。The implant described in any one of claims 1-6, the component described in any one of claims 7-11, or the interventional artificial chordae tendineae repair device described in any one of claims 12-16 is being prepared for the treatment of mitral valve regurgitation use in the product.
PCT/CN2021/074686 2020-08-03 2021-02-01 Implant and assembly used in forming same WO2022027941A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CN202021581035.6 2020-08-03
CN202010769208.5 2020-08-03
CN202021581035.6U CN212730074U (en) 2020-08-03 2020-08-03 Implant, assembly for forming implant and interventional artificial chordae repair device
CN202010769208.5A CN114052986A (en) 2020-08-03 2020-08-03 Implant and assembly for forming an implant

Publications (1)

Publication Number Publication Date
WO2022027941A1 true WO2022027941A1 (en) 2022-02-10

Family

ID=80116901

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2021/074686 WO2022027941A1 (en) 2020-08-03 2021-02-01 Implant and assembly used in forming same

Country Status (1)

Country Link
WO (1) WO2022027941A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115634076A (en) * 2022-10-08 2023-01-24 瀚芯医疗科技(深圳)有限公司 Artificial chordae tendineae clamping device and manipulator

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101902975A (en) * 2007-10-18 2010-12-01 尼奥绰德有限公司 Minimally invasive repair of a valve leaflet in a beating heart
WO2013003228A1 (en) * 2011-06-27 2013-01-03 University Of Maryland, Baltimore Transapical mitral valve repair device
CN103889345A (en) * 2011-04-15 2014-06-25 心脏缝合有限公司 Suturing devices and methods for suturing an anatomic valve
CN104248457A (en) * 2014-09-03 2014-12-31 郭文彬 Artificial chordae tendineae device and threading element and suite
US20170258464A1 (en) * 2014-01-03 2017-09-14 Harpoon Medical, Inc. Method and apparatus for transapical procedures on a mitral valve
CN108697418A (en) * 2015-11-02 2018-10-23 马里兰大学巴尔的摩分校 Distal side anchoring device and method for mitral valve reparation
US20190380705A1 (en) * 2015-10-02 2019-12-19 Ceterix Orthopaedics, Inc. Knot tying accessory
CN110650710A (en) * 2017-04-06 2020-01-03 哈珀恩医疗有限公司 Distal anchor apparatus and methods for mitral valve repair
CN111467081A (en) * 2020-03-30 2020-07-31 科凯(南通)生命科学有限公司 Multi-point fixed artificial chordae tendineae implanting device

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101902975A (en) * 2007-10-18 2010-12-01 尼奥绰德有限公司 Minimally invasive repair of a valve leaflet in a beating heart
CN103889345A (en) * 2011-04-15 2014-06-25 心脏缝合有限公司 Suturing devices and methods for suturing an anatomic valve
WO2013003228A1 (en) * 2011-06-27 2013-01-03 University Of Maryland, Baltimore Transapical mitral valve repair device
US20170258464A1 (en) * 2014-01-03 2017-09-14 Harpoon Medical, Inc. Method and apparatus for transapical procedures on a mitral valve
CN104248457A (en) * 2014-09-03 2014-12-31 郭文彬 Artificial chordae tendineae device and threading element and suite
US20190380705A1 (en) * 2015-10-02 2019-12-19 Ceterix Orthopaedics, Inc. Knot tying accessory
CN108697418A (en) * 2015-11-02 2018-10-23 马里兰大学巴尔的摩分校 Distal side anchoring device and method for mitral valve reparation
CN110650710A (en) * 2017-04-06 2020-01-03 哈珀恩医疗有限公司 Distal anchor apparatus and methods for mitral valve repair
CN111467081A (en) * 2020-03-30 2020-07-31 科凯(南通)生命科学有限公司 Multi-point fixed artificial chordae tendineae implanting device

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115634076A (en) * 2022-10-08 2023-01-24 瀚芯医疗科技(深圳)有限公司 Artificial chordae tendineae clamping device and manipulator
CN115634076B (en) * 2022-10-08 2023-09-01 瀚芯医疗科技(深圳)有限公司 Artificial tendon grip and manipulator

Similar Documents

Publication Publication Date Title
US11622759B2 (en) Systems and methods for anchoring an implant
US11744573B2 (en) Devices and methods for locating and implanting tissue anchors at mitral valve commissure
CN110913772B (en) Delivery systems and methods for reshaping a heart valve annulus, including the use of magnetic tools
US10512542B2 (en) Device, system, and method for transcatheter treatment of valve regurgitation
US10172621B2 (en) Devices, systems, and methods for reshaping a heart valve annulus, including the use of magnetic tools
JP5371440B2 (en) Papillary muscle position control device, system and method
US7004176B2 (en) Heart valve leaflet locator
US20080288060A1 (en) Treating Valvular Insufficiency
JP2003521310A (en) Percutaneous mitral valve annuloplasty and cardiac augmentation
SE531468C2 (en) An apparatus for controlling blood flow
CA2877344A1 (en) Device, system, and method for transcatheter treatment of valve regurgitation
CN109498216A (en) A kind of drag wire locking catheters for valve reparation
JP2008534085A (en) Apparatus, system, and method for reshaping a heart valve annulus
US20170216031A1 (en) Devices, systems, and methods for reshaping a heart valve anulus, including the use of a bridge implant having an adjustable bridge stop
WO2022027941A1 (en) Implant and assembly used in forming same
Buchanan et al. Circumferential suture of the mitral annulus for correction of mitral regurgitation in dogs
CN113827285A (en) Closure device for tissue defects
WO2023040272A1 (en) Tissue defect closure instrument
CN111374800A (en) Valve ring-contracting system
CN212730074U (en) Implant, assembly for forming implant and interventional artificial chordae repair device
WO2020134053A1 (en) Valve annulus shrinkage system
WO2020134052A1 (en) Single window-guided valve annulus reduction system
CN114052986A (en) Implant and assembly for forming an implant
CN216702724U (en) Valve leaflet anchoring piece and artificial chordae tendineae repairing device
CN209966663U (en) Valve ring-contracting system

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 21854285

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 21854285

Country of ref document: EP

Kind code of ref document: A1